{
  "directed": true,
  "graph": {
    "annotation_list": {
      "PublicationType": [
        "Comment",
        "Research",
        "Review"
      ]
    },
    "annotation_pattern": {},
    "annotation_url": {
      "CellStructure": "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/cell-structure/cell-structure-20170511.belanno",
      "Confidence": "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/confidence/confidence-1.0.0.belanno",
      "MeSHAnatomy": "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/mesh-anatomy/mesh-anatomy-20170511.belanno",
      "MeSHDisease": "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/mesh-diseases/mesh-diseases-20170511.belanno"
    },
    "document_metadata": {
      "authors": "Sandra Spalek and Charles Tapley Hoyt",
      "contact": "charles.hoyt@scai.fraunhofer.de",
      "copyright": "Copyright © 2018 Fraunhofer Institute SCAI, All rights reserved",
      "description": "Tau oligomers-Cytotoxicity, propagation, and mitochondrial damage from Shafiei et al., 2017",
      "licenses": "CC BY 4.0",
      "name": "Tau oligomers-Cytotoxicity, propagation, and mitochondrial damage",
      "version": "1.0.0"
    },
    "namespace_pattern": {},
    "namespace_url": {
      "CHEBI": "https://arty.scai.fraunhofer.de/artifactory/bel/namespace/chebi/chebi-20180106.belns",
      "CONSO": "https://raw.githubusercontent.com/pharmacome/conso/501ceccdc9a27d97edbdc48a89ebe8e1dd3626e9/export/conso-names.belns",
      "GO": "https://raw.githubusercontent.com/pharmacome/terminology/73688d6dc24e309fca59a1340dc9ee971e9f3baa/external/go-names.belns",
      "HGNC": "https://arty.scai.fraunhofer.de/artifactory/bel/namespace/hgnc/hgnc-20180215.belns",
      "HP": "https://arty.scai.fraunhofer.de/artifactory/bel/namespace/hp/hp-20171108.belns",
      "MESH": "https://raw.githubusercontent.com/pharmacome/terminology/1b20f0637c395f8aa89c2e2e342d7b704062c242/external/mesh-names.belns"
    },
    "path": "tau/shafiei2017.bel",
    "pybel_version": "0.14.10"
  },
  "links": [
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "PublicationType": {
          "Review": true
        }
      },
      "citation": {
        "authors": [
          "Castillo-Carranza DL",
          "Guerrero-Muñoz MJ",
          "Shafiei SS"
        ],
        "date": "2017-01-01",
        "db": "PubMed",
        "db_id": "28420982",
        "db_name": "Tau Oligomers: Cytotoxicity, Propagation, and Mitochondrial Damage.",
        "first": "Shafiei SS",
        "journal": "Frontiers in aging neuroscience",
        "last": "Castillo-Carranza DL",
        "pages": "83",
        "volume": "9"
      },
      "evidence": "These share a common histopathological hallmark known as neurofibrillary tangles (NFTs) that consist of an accumulation of fibrillar tau deposits initially produced from tau protein aggregation (Ballatore et al., 2007)",
      "key": "7822582bef0d456e7303dcb647f92100",
      "line": 51,
      "relation": "increases",
      "source": 2,
      "target": 10
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHAnatomy": {
          "Cerebral Cortex": true
        },
        "PublicationType": {
          "Review": true
        }
      },
      "citation": {
        "authors": [
          "Castillo-Carranza DL",
          "Guerrero-Muñoz MJ",
          "Shafiei SS"
        ],
        "date": "2017-01-01",
        "db": "PubMed",
        "db_id": "28420982",
        "db_name": "Tau Oligomers: Cytotoxicity, Propagation, and Mitochondrial Damage.",
        "first": "Shafiei SS",
        "journal": "Frontiers in aging neuroscience",
        "last": "Castillo-Carranza DL",
        "pages": "83",
        "volume": "9"
      },
      "evidence": "Additionally, studies have discovered that aggregated tau inhibits fast axonal transport in the anterograde direction at all physiological tau levels, whereas tau monomers have had no effect in either direction (LaPointe et al., 2009; Morfini et al., 2009)",
      "key": "06ee7f8a14e2d44d799228c564db81d5",
      "line": 159,
      "relation": "decreases",
      "source": 2,
      "target": 21
    },
    {
      "annotations": {
        "Confidence": {
          "Low": true
        },
        "MeSHAnatomy": {
          "Entorhinal Cortex": true
        },
        "PublicationType": {
          "Review": true
        }
      },
      "citation": {
        "authors": [
          "Castillo-Carranza DL",
          "Guerrero-Muñoz MJ",
          "Shafiei SS"
        ],
        "date": "2017-01-01",
        "db": "PubMed",
        "db_id": "28420982",
        "db_name": "Tau Oligomers: Cytotoxicity, Propagation, and Mitochondrial Damage.",
        "first": "Shafiei SS",
        "journal": "Frontiers in aging neuroscience",
        "last": "Castillo-Carranza DL",
        "pages": "83",
        "volume": "9"
      },
      "evidence": "A recent study showed that neuronal networks facilitate cell-to-cell transfer of tau via synapses; using a microfluidic device they demonstrated that decreasing synaptic connections weakens tau transfer and the subsequent aggregation on the acceptor cell (Calafate et al., 2015)",
      "key": "6e752330238c2f7fb32445e64a119eaa",
      "line": 233,
      "relation": "association",
      "source": 2,
      "target": 38
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        },
        "MeSHAnatomy": {
          "Exosomes": true
        },
        "MeSHDisease": {
          "Alzheimer Disease": true
        },
        "PublicationType": {
          "Review": true
        }
      },
      "citation": {
        "authors": [
          "Castillo-Carranza DL",
          "Guerrero-Muñoz MJ",
          "Shafiei SS"
        ],
        "date": "2017-01-01",
        "db": "PubMed",
        "db_id": "28420982",
        "db_name": "Tau Oligomers: Cytotoxicity, Propagation, and Mitochondrial Damage.",
        "first": "Shafiei SS",
        "journal": "Frontiers in aging neuroscience",
        "last": "Castillo-Carranza DL",
        "pages": "83",
        "volume": "9"
      },
      "evidence": "Significantly, evidence suggests that tau secretion is partly mediated by ectosomal vesicles and that pathological tau accumulation in cells leads to a deviation toward tau secretion by exosomal vesicles (Dujardin et al., 2014a)",
      "key": "790e17515c8bda45bc578ebd184fd8a6",
      "line": 294,
      "object": {
        "effect": {
          "fromLoc": {
            "name": "intracellular",
            "namespace": "bel"
          },
          "toLoc": {
            "name": "extracellular space",
            "namespace": "bel"
          }
        },
        "modifier": "Translocation"
      },
      "relation": "association",
      "source": 2,
      "target": 54
    },
    {
      "annotations": {
        "CellStructure": {
          "Extracellular Space": true
        },
        "Confidence": {
          "High": true
        },
        "MeSHAnatomy": {
          "Exosomes": true
        },
        "MeSHDisease": {
          "Alzheimer Disease": true
        },
        "PublicationType": {
          "Review": true
        }
      },
      "citation": {
        "authors": [
          "Castillo-Carranza DL",
          "Guerrero-Muñoz MJ",
          "Shafiei SS"
        ],
        "date": "2017-01-01",
        "db": "PubMed",
        "db_id": "28420982",
        "db_name": "Tau Oligomers: Cytotoxicity, Propagation, and Mitochondrial Damage.",
        "first": "Shafiei SS",
        "journal": "Frontiers in aging neuroscience",
        "last": "Castillo-Carranza DL",
        "pages": "83",
        "volume": "9"
      },
      "evidence": "Evidence shows that tau aggregates colocalize with dextran and HeLa cells, hinting that internalized aggregates are transported in endosomal vesicles and passed through the endosomal pathway to lysosomes (Wu et al., 2013)",
      "key": "71bb761b1f5ea166bdec05b9bf1e7359",
      "line": 332,
      "relation": "association",
      "source": 2,
      "target": 1
    },
    {
      "key": "859945aba620d4880649d6cfec8c8c69",
      "relation": "partOf",
      "source": 2,
      "target": 41
    },
    {
      "key": "860fbe923e02c5829a199066e49caceb",
      "relation": "partOf",
      "source": 2,
      "target": 40
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        },
        "MeSHAnatomy": {
          "Cerebral Cortex": true
        },
        "PublicationType": {
          "Review": true
        }
      },
      "citation": {
        "authors": [
          "Castillo-Carranza DL",
          "Guerrero-Muñoz MJ",
          "Shafiei SS"
        ],
        "date": "2017-01-01",
        "db": "PubMed",
        "db_id": "28420982",
        "db_name": "Tau Oligomers: Cytotoxicity, Propagation, and Mitochondrial Damage.",
        "first": "Shafiei SS",
        "journal": "Frontiers in aging neuroscience",
        "last": "Castillo-Carranza DL",
        "pages": "83",
        "volume": "9"
      },
      "evidence": "Compared to non-demented controls, AD brains exhibit up to 50% of neuronal loss in the cortex, exceeding the number of NFTs (Gómez-Isla et al., 1997)",
      "key": "4a4075c313aeef9a2c391b942be1c337",
      "line": 73,
      "relation": "positiveCorrelation",
      "source": 10,
      "target": 61
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "PublicationType": {
          "Review": true
        }
      },
      "citation": {
        "authors": [
          "Castillo-Carranza DL",
          "Guerrero-Muñoz MJ",
          "Shafiei SS"
        ],
        "date": "2017-01-01",
        "db": "PubMed",
        "db_id": "28420982",
        "db_name": "Tau Oligomers: Cytotoxicity, Propagation, and Mitochondrial Damage.",
        "first": "Shafiei SS",
        "journal": "Frontiers in aging neuroscience",
        "last": "Castillo-Carranza DL",
        "pages": "83",
        "volume": "9"
      },
      "evidence": "While functional tau is an unfolded monomeric protein that stabilizes microtubules, regulates neurite growth, and monitors axonal transport of organelles (Medina and Avila, 2014), dysfunctional tau acquires a new toxic function",
      "key": "4a0728eb3b48dbe650c8d281d351ca5f",
      "line": 57,
      "relation": "increases",
      "source": 54,
      "target": 11
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "PublicationType": {
          "Review": true
        }
      },
      "citation": {
        "authors": [
          "Castillo-Carranza DL",
          "Guerrero-Muñoz MJ",
          "Shafiei SS"
        ],
        "date": "2017-01-01",
        "db": "PubMed",
        "db_id": "28420982",
        "db_name": "Tau Oligomers: Cytotoxicity, Propagation, and Mitochondrial Damage.",
        "first": "Shafiei SS",
        "journal": "Frontiers in aging neuroscience",
        "last": "Castillo-Carranza DL",
        "pages": "83",
        "volume": "9"
      },
      "evidence": "While functional tau is an unfolded monomeric protein that stabilizes microtubules, regulates neurite growth, and monitors axonal transport of organelles (Medina and Avila, 2014), dysfunctional tau acquires a new toxic function",
      "key": "d7877d2aa6b2601765b79f982380acf2",
      "line": 58,
      "relation": "regulates",
      "source": 54,
      "target": 24
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "PublicationType": {
          "Review": true
        }
      },
      "citation": {
        "authors": [
          "Castillo-Carranza DL",
          "Guerrero-Muñoz MJ",
          "Shafiei SS"
        ],
        "date": "2017-01-01",
        "db": "PubMed",
        "db_id": "28420982",
        "db_name": "Tau Oligomers: Cytotoxicity, Propagation, and Mitochondrial Damage.",
        "first": "Shafiei SS",
        "journal": "Frontiers in aging neuroscience",
        "last": "Castillo-Carranza DL",
        "pages": "83",
        "volume": "9"
      },
      "evidence": "While functional tau is an unfolded monomeric protein that stabilizes microtubules, regulates neurite growth, and monitors axonal transport of organelles (Medina and Avila, 2014), dysfunctional tau acquires a new toxic function",
      "key": "36736bd75cd6914ec92d380a615a631d",
      "line": 59,
      "relation": "regulates",
      "source": 54,
      "target": 22
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        },
        "MeSHAnatomy": {
          "Cerebral Cortex": true
        },
        "PublicationType": {
          "Review": true
        }
      },
      "citation": {
        "authors": [
          "Castillo-Carranza DL",
          "Guerrero-Muñoz MJ",
          "Shafiei SS"
        ],
        "date": "2017-01-01",
        "db": "PubMed",
        "db_id": "28420982",
        "db_name": "Tau Oligomers: Cytotoxicity, Propagation, and Mitochondrial Damage.",
        "first": "Shafiei SS",
        "journal": "Frontiers in aging neuroscience",
        "last": "Castillo-Carranza DL",
        "pages": "83",
        "volume": "9"
      },
      "evidence": "While evidence has linked FTD with parkinsonism in patients to tau mutations on chromosome 17 (FTDP-17), implying that tau dysfunction alone can cause neurodegeneration (Reed et al., 2001), studies in animal models have shown that overexpression of tau can lead to cell death (Lee et al., 2001; Tanemura et al., 2001, 2002; Tatebayashi et al., 2002) and exhibit behavioral abnormalities and synaptic dysfunction without the presence of NFTs (Wittmann et al., 2001; Andorfer et al., 2003; Santacruz et al., 2005; Spires et al., 2006; Berger et al., 2007; Yoshiyama et al., 2007; Cowan et al., 2010)",
      "key": "b301cbb33985aa57531110119e46bb15",
      "line": 87,
      "relation": "increases",
      "source": 54,
      "target": 36
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        },
        "MeSHAnatomy": {
          "Cerebral Cortex": true
        },
        "PublicationType": {
          "Review": true
        }
      },
      "citation": {
        "authors": [
          "Castillo-Carranza DL",
          "Guerrero-Muñoz MJ",
          "Shafiei SS"
        ],
        "date": "2017-01-01",
        "db": "PubMed",
        "db_id": "28420982",
        "db_name": "Tau Oligomers: Cytotoxicity, Propagation, and Mitochondrial Damage.",
        "first": "Shafiei SS",
        "journal": "Frontiers in aging neuroscience",
        "last": "Castillo-Carranza DL",
        "pages": "83",
        "volume": "9"
      },
      "evidence": "While evidence has linked FTD with parkinsonism in patients to tau mutations on chromosome 17 (FTDP-17), implying that tau dysfunction alone can cause neurodegeneration (Reed et al., 2001), studies in animal models have shown that overexpression of tau can lead to cell death (Lee et al., 2001; Tanemura et al., 2001, 2002; Tatebayashi et al., 2002) and exhibit behavioral abnormalities and synaptic dysfunction without the presence of NFTs (Wittmann et al., 2001; Andorfer et al., 2003; Santacruz et al., 2005; Spires et al., 2006; Berger et al., 2007; Yoshiyama et al., 2007; Cowan et al., 2010)",
      "key": "051bb11c9eaf6ecbfcb83bee5ccd84ce",
      "line": 88,
      "relation": "increases",
      "source": 54,
      "target": 23
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        },
        "MeSHAnatomy": {
          "Cerebral Cortex": true
        },
        "PublicationType": {
          "Review": true
        }
      },
      "citation": {
        "authors": [
          "Castillo-Carranza DL",
          "Guerrero-Muñoz MJ",
          "Shafiei SS"
        ],
        "date": "2017-01-01",
        "db": "PubMed",
        "db_id": "28420982",
        "db_name": "Tau Oligomers: Cytotoxicity, Propagation, and Mitochondrial Damage.",
        "first": "Shafiei SS",
        "journal": "Frontiers in aging neuroscience",
        "last": "Castillo-Carranza DL",
        "pages": "83",
        "volume": "9"
      },
      "evidence": "While evidence has linked FTD with parkinsonism in patients to tau mutations on chromosome 17 (FTDP-17), implying that tau dysfunction alone can cause neurodegeneration (Reed et al., 2001), studies in animal models have shown that overexpression of tau can lead to cell death (Lee et al., 2001; Tanemura et al., 2001, 2002; Tatebayashi et al., 2002) and exhibit behavioral abnormalities and synaptic dysfunction without the presence of NFTs (Wittmann et al., 2001; Andorfer et al., 2003; Santacruz et al., 2005; Spires et al., 2006; Berger et al., 2007; Yoshiyama et al., 2007; Cowan et al., 2010)",
      "key": "f3c29206ed86c137a5694aaece95f59f",
      "line": 89,
      "relation": "association",
      "source": 54,
      "target": 31
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        },
        "MeSHAnatomy": {
          "Cerebral Cortex": true
        },
        "PublicationType": {
          "Review": true
        }
      },
      "citation": {
        "authors": [
          "Castillo-Carranza DL",
          "Guerrero-Muñoz MJ",
          "Shafiei SS"
        ],
        "date": "2017-01-01",
        "db": "PubMed",
        "db_id": "28420982",
        "db_name": "Tau Oligomers: Cytotoxicity, Propagation, and Mitochondrial Damage.",
        "first": "Shafiei SS",
        "journal": "Frontiers in aging neuroscience",
        "last": "Castillo-Carranza DL",
        "pages": "83",
        "volume": "9"
      },
      "evidence": "While evidence has linked FTD with parkinsonism in patients to tau mutations on chromosome 17 (FTDP-17), implying that tau dysfunction alone can cause neurodegeneration (Reed et al., 2001), studies in animal models have shown that overexpression of tau can lead to cell death (Lee et al., 2001; Tanemura et al., 2001, 2002; Tatebayashi et al., 2002) and exhibit behavioral abnormalities and synaptic dysfunction without the presence of NFTs (Wittmann et al., 2001; Andorfer et al., 2003; Santacruz et al., 2005; Spires et al., 2006; Berger et al., 2007; Yoshiyama et al., 2007; Cowan et al., 2010)",
      "key": "1f725f6367a3878b98cc7f5a505f196a",
      "line": 90,
      "relation": "decreases",
      "source": 54,
      "target": 30
    },
    {
      "key": "064f60bbd4e86ec0d71e89e733af2e71",
      "relation": "hasVariant",
      "source": 54,
      "target": 57
    },
    {
      "key": "b5598bdf6efd9fde812f328d4b265819",
      "relation": "partOf",
      "source": 54,
      "target": 43
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        },
        "MeSHAnatomy": {
          "Hippocampus": true
        },
        "PublicationType": {
          "Review": true
        }
      },
      "citation": {
        "authors": [
          "Castillo-Carranza DL",
          "Guerrero-Muñoz MJ",
          "Shafiei SS"
        ],
        "date": "2017-01-01",
        "db": "PubMed",
        "db_id": "28420982",
        "db_name": "Tau Oligomers: Cytotoxicity, Propagation, and Mitochondrial Damage.",
        "first": "Shafiei SS",
        "journal": "Frontiers in aging neuroscience",
        "last": "Castillo-Carranza DL",
        "pages": "83",
        "volume": "9"
      },
      "evidence": "This hints that tau plays a role in monitoring intracellular signaling pathways (Pooler and Hanger, 2010)",
      "key": "8fe64e16498a411954f1d89bd1939680",
      "line": 199,
      "relation": "association",
      "source": 54,
      "target": 25
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        },
        "MeSHAnatomy": {
          "Cerebrospinal Fluid": true
        },
        "PublicationType": {
          "Review": true
        }
      },
      "citation": {
        "authors": [
          "Castillo-Carranza DL",
          "Guerrero-Muñoz MJ",
          "Shafiei SS"
        ],
        "date": "2017-01-01",
        "db": "PubMed",
        "db_id": "28420982",
        "db_name": "Tau Oligomers: Cytotoxicity, Propagation, and Mitochondrial Damage.",
        "first": "Shafiei SS",
        "journal": "Frontiers in aging neuroscience",
        "last": "Castillo-Carranza DL",
        "pages": "83",
        "volume": "9"
      },
      "evidence": "In AD, the quantity of tau identified in the CSF increases with disease progression (Hampel et al., 2010). However, the mechanism of tau propagation from the brain to the CSF remains elusive",
      "key": "557253d2b044051cd16f2000c1a57610",
      "line": 207,
      "relation": "positiveCorrelation",
      "source": 54,
      "target": 61
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        },
        "MeSHAnatomy": {
          "Cerebrospinal Fluid": true
        },
        "MeSHDisease": {
          "Alzheimer Disease": true
        },
        "PublicationType": {
          "Review": true
        }
      },
      "citation": {
        "authors": [
          "Castillo-Carranza DL",
          "Guerrero-Muñoz MJ",
          "Shafiei SS"
        ],
        "date": "2017-01-01",
        "db": "PubMed",
        "db_id": "28420982",
        "db_name": "Tau Oligomers: Cytotoxicity, Propagation, and Mitochondrial Damage.",
        "first": "Shafiei SS",
        "journal": "Frontiers in aging neuroscience",
        "last": "Castillo-Carranza DL",
        "pages": "83",
        "volume": "9"
      },
      "evidence": "More recently, patients affected with FTD and AD, were found to have high levels of total tau and phosphorylated tau (p-T181 and p-S396; Saman et al., 2012)",
      "key": "32cc25c7b611243ef27b01b3df809890",
      "line": 271,
      "relation": "positiveCorrelation",
      "source": 54,
      "target": 61
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        },
        "MeSHAnatomy": {
          "Entorhinal Cortex": true
        },
        "PublicationType": {
          "Review": true
        }
      },
      "citation": {
        "authors": [
          "Castillo-Carranza DL",
          "Guerrero-Muñoz MJ",
          "Shafiei SS"
        ],
        "date": "2017-01-01",
        "db": "PubMed",
        "db_id": "28420982",
        "db_name": "Tau Oligomers: Cytotoxicity, Propagation, and Mitochondrial Damage.",
        "first": "Shafiei SS",
        "journal": "Frontiers in aging neuroscience",
        "last": "Castillo-Carranza DL",
        "pages": "83",
        "volume": "9"
      },
      "evidence": "Further, transgenic mouse lines expressing human tau aggregates in the entorhinal cortex have shown that tau is mislocalized from axons to cell bodies and dendrites as the mice age (Pooler et al., 2013b)",
      "key": "6c910cfe968c1b37a38524e2c9259296",
      "line": 223,
      "relation": "association",
      "source": 54,
      "subject": {
        "effect": {
          "fromLoc": {
            "name": "axon",
            "namespace": "GO"
          },
          "toLoc": {
            "name": "cell body",
            "namespace": "GO"
          }
        },
        "modifier": "Translocation"
      },
      "target": 39
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        },
        "MeSHAnatomy": {
          "Entorhinal Cortex": true
        },
        "PublicationType": {
          "Review": true
        }
      },
      "citation": {
        "authors": [
          "Castillo-Carranza DL",
          "Guerrero-Muñoz MJ",
          "Shafiei SS"
        ],
        "date": "2017-01-01",
        "db": "PubMed",
        "db_id": "28420982",
        "db_name": "Tau Oligomers: Cytotoxicity, Propagation, and Mitochondrial Damage.",
        "first": "Shafiei SS",
        "journal": "Frontiers in aging neuroscience",
        "last": "Castillo-Carranza DL",
        "pages": "83",
        "volume": "9"
      },
      "evidence": "Further, transgenic mouse lines expressing human tau aggregates in the entorhinal cortex have shown that tau is mislocalized from axons to cell bodies and dendrites as the mice age (Pooler et al., 2013b)",
      "key": "0ea374cf427373db1e56983a4122a88f",
      "line": 224,
      "relation": "association",
      "source": 54,
      "subject": {
        "effect": {
          "fromLoc": {
            "name": "axon",
            "namespace": "GO"
          },
          "toLoc": {
            "name": "dendrite",
            "namespace": "GO"
          }
        },
        "modifier": "Translocation"
      },
      "target": 39
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHAnatomy": {
          "Neocortex": true
        },
        "PublicationType": {
          "Review": true
        }
      },
      "citation": {
        "authors": [
          "Castillo-Carranza DL",
          "Guerrero-Muñoz MJ",
          "Shafiei SS"
        ],
        "date": "2017-01-01",
        "db": "PubMed",
        "db_id": "28420982",
        "db_name": "Tau Oligomers: Cytotoxicity, Propagation, and Mitochondrial Damage.",
        "first": "Shafiei SS",
        "journal": "Frontiers in aging neuroscience",
        "last": "Castillo-Carranza DL",
        "pages": "83",
        "volume": "9"
      },
      "evidence": "Recently, more evidence implies that the secretion of tau occurs through unconventional cellular pathways via vesicles known as exosomes (Saman et al., 2012) and ectosomes (Dujardin et al., 2014a)",
      "key": "9181abd910465645d402b4f362db4348",
      "line": 247,
      "relation": "association",
      "source": 54,
      "subject": {
        "effect": {
          "fromLoc": {
            "name": "intracellular",
            "namespace": "bel"
          },
          "toLoc": {
            "name": "extracellular space",
            "namespace": "bel"
          }
        },
        "modifier": "Translocation"
      },
      "target": 19
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHAnatomy": {
          "Neocortex": true
        },
        "PublicationType": {
          "Review": true
        }
      },
      "citation": {
        "authors": [
          "Castillo-Carranza DL",
          "Guerrero-Muñoz MJ",
          "Shafiei SS"
        ],
        "date": "2017-01-01",
        "db": "PubMed",
        "db_id": "28420982",
        "db_name": "Tau Oligomers: Cytotoxicity, Propagation, and Mitochondrial Damage.",
        "first": "Shafiei SS",
        "journal": "Frontiers in aging neuroscience",
        "last": "Castillo-Carranza DL",
        "pages": "83",
        "volume": "9"
      },
      "evidence": "Recently, more evidence implies that the secretion of tau occurs through unconventional cellular pathways via vesicles known as exosomes (Saman et al., 2012) and ectosomes (Dujardin et al., 2014a)",
      "key": "1c2ea01978b55c09bf011eb46c226b85",
      "line": 248,
      "relation": "association",
      "source": 54,
      "subject": {
        "effect": {
          "fromLoc": {
            "name": "intracellular",
            "namespace": "bel"
          },
          "toLoc": {
            "name": "extracellular space",
            "namespace": "bel"
          }
        },
        "modifier": "Translocation"
      },
      "target": 12
    },
    {
      "key": "c40aee43d27f1806c59dcbf2b7ba2c1a",
      "relation": "hasVariant",
      "source": 54,
      "target": 59
    },
    {
      "key": "deebc6415a1d74c0501fe5fae6165d64",
      "relation": "hasVariant",
      "source": 54,
      "target": 58
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        },
        "MeSHAnatomy": {
          "Cerebrospinal Fluid": true
        },
        "MeSHDisease": {
          "Alzheimer Disease": true
        },
        "PublicationType": {
          "Review": true
        }
      },
      "citation": {
        "authors": [
          "Castillo-Carranza DL",
          "Guerrero-Muñoz MJ",
          "Shafiei SS"
        ],
        "date": "2017-01-01",
        "db": "PubMed",
        "db_id": "28420982",
        "db_name": "Tau Oligomers: Cytotoxicity, Propagation, and Mitochondrial Damage.",
        "first": "Shafiei SS",
        "journal": "Frontiers in aging neuroscience",
        "last": "Castillo-Carranza DL",
        "pages": "83",
        "volume": "9"
      },
      "evidence": "More recently, patients affected with FTD and AD, were found to have high levels of total tau and phosphorylated tau (p-T181 and p-S396; Saman et al., 2012)",
      "key": "5d99fc7451f0369cd3efb81579940137",
      "line": 274,
      "relation": "positiveCorrelation",
      "source": 54,
      "target": 64
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        },
        "MeSHAnatomy": {
          "Exosomes": true
        },
        "MeSHDisease": {
          "Alzheimer Disease": true
        },
        "PublicationType": {
          "Review": true
        }
      },
      "citation": {
        "authors": [
          "Castillo-Carranza DL",
          "Guerrero-Muñoz MJ",
          "Shafiei SS"
        ],
        "date": "2017-01-01",
        "db": "PubMed",
        "db_id": "28420982",
        "db_name": "Tau Oligomers: Cytotoxicity, Propagation, and Mitochondrial Damage.",
        "first": "Shafiei SS",
        "journal": "Frontiers in aging neuroscience",
        "last": "Castillo-Carranza DL",
        "pages": "83",
        "volume": "9"
      },
      "evidence": "Significantly, evidence suggests that tau secretion is partly mediated by ectosomal vesicles and that pathological tau accumulation in cells leads to a deviation toward tau secretion by exosomal vesicles (Dujardin et al., 2014a)",
      "key": "10f307bdea1541a1326341ae11616c34",
      "line": 294,
      "relation": "association",
      "source": 54,
      "subject": {
        "effect": {
          "fromLoc": {
            "name": "intracellular",
            "namespace": "bel"
          },
          "toLoc": {
            "name": "extracellular space",
            "namespace": "bel"
          }
        },
        "modifier": "Translocation"
      },
      "target": 2
    },
    {
      "annotations": {
        "CellStructure": {
          "Intracellular Space": true
        },
        "Confidence": {
          "Medium": true
        },
        "MeSHAnatomy": {
          "Exosomes": true
        },
        "MeSHDisease": {
          "Alzheimer Disease": true
        },
        "PublicationType": {
          "Review": true
        }
      },
      "citation": {
        "authors": [
          "Castillo-Carranza DL",
          "Guerrero-Muñoz MJ",
          "Shafiei SS"
        ],
        "date": "2017-01-01",
        "db": "PubMed",
        "db_id": "28420982",
        "db_name": "Tau Oligomers: Cytotoxicity, Propagation, and Mitochondrial Damage.",
        "first": "Shafiei SS",
        "journal": "Frontiers in aging neuroscience",
        "last": "Castillo-Carranza DL",
        "pages": "83",
        "volume": "9"
      },
      "evidence": "Tau may be endocytosed, promoting an increase in intracellular calcium that results in neuronal death",
      "key": "13b26030722a4ae8875f46c36a8e2c4d",
      "line": 300,
      "relation": "increases",
      "source": 54,
      "target": 0
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        },
        "MeSHAnatomy": {
          "Exosomes": true
        },
        "MeSHDisease": {
          "Alzheimer Disease": true
        },
        "PublicationType": {
          "Review": true
        }
      },
      "citation": {
        "authors": [
          "Castillo-Carranza DL",
          "Guerrero-Muñoz MJ",
          "Shafiei SS"
        ],
        "date": "2017-01-01",
        "db": "PubMed",
        "db_id": "28420982",
        "db_name": "Tau Oligomers: Cytotoxicity, Propagation, and Mitochondrial Damage.",
        "first": "Shafiei SS",
        "journal": "Frontiers in aging neuroscience",
        "last": "Castillo-Carranza DL",
        "pages": "83",
        "volume": "9"
      },
      "evidence": "Tau may be endocytosed, promoting an increase in intracellular calcium that results in neuronal death",
      "key": "2631ae3a2f6b25935c4307fd1bc2389f",
      "line": 302,
      "relation": "increases",
      "source": 54,
      "target": 29
    },
    {
      "key": "ed4f57c34fc0bec6f7afb4bedb90c4db",
      "relation": "partOf",
      "source": 54,
      "target": 45
    },
    {
      "key": "0d9576d4d2c7d632084eb51edd9d4b08",
      "relation": "partOf",
      "source": 54,
      "target": 46
    },
    {
      "key": "427fffb9c33dd12f12c94c9cf964bc1b",
      "relation": "partOf",
      "source": 54,
      "target": 47
    },
    {
      "key": "ae92168137c0f965e4db93aae5018b52",
      "relation": "hasVariant",
      "source": 54,
      "target": 55
    },
    {
      "key": "5bc84b2b0e64e56db83fb23857599eaf",
      "relation": "hasVariant",
      "source": 54,
      "target": 56
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "PublicationType": {
          "Review": true
        }
      },
      "citation": {
        "authors": [
          "Castillo-Carranza DL",
          "Guerrero-Muñoz MJ",
          "Shafiei SS"
        ],
        "date": "2017-01-01",
        "db": "PubMed",
        "db_id": "28420982",
        "db_name": "Tau Oligomers: Cytotoxicity, Propagation, and Mitochondrial Damage.",
        "first": "Shafiei SS",
        "journal": "Frontiers in aging neuroscience",
        "last": "Castillo-Carranza DL",
        "pages": "83",
        "volume": "9"
      },
      "evidence": "In AD, tau pathology and neuronal cell loss coincide in the same brain regions, and as brain dysfunction progresses, NFTs are found in greater anatomical distributions (Ihara, 2001)",
      "key": "188d4e87c63aa9359162b8df947cab36",
      "line": 65,
      "relation": "association",
      "source": 68,
      "target": 29
    },
    {
      "annotations": {
        "CellStructure": {
          "Extracellular Space": true
        },
        "Confidence": {
          "High": true
        },
        "MeSHAnatomy": {
          "Neurons": true
        },
        "MeSHDisease": {
          "Alzheimer Disease": true
        },
        "PublicationType": {
          "Review": true
        }
      },
      "citation": {
        "authors": [
          "Castillo-Carranza DL",
          "Guerrero-Muñoz MJ",
          "Shafiei SS"
        ],
        "date": "2017-01-01",
        "db": "PubMed",
        "db_id": "28420982",
        "db_name": "Tau Oligomers: Cytotoxicity, Propagation, and Mitochondrial Damage.",
        "first": "Shafiei SS",
        "journal": "Frontiers in aging neuroscience",
        "last": "Castillo-Carranza DL",
        "pages": "83",
        "volume": "9"
      },
      "evidence": "Hence, tau APFs may play a significant role in tauopathies by linking pore formation to cell death",
      "key": "562e5cd7a595d432c44fd3c1b95b555c",
      "line": 391,
      "relation": "association",
      "source": 68,
      "target": 3
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "PublicationType": {
          "Review": true
        }
      },
      "citation": {
        "authors": [
          "Castillo-Carranza DL",
          "Guerrero-Muñoz MJ",
          "Shafiei SS"
        ],
        "date": "2017-01-01",
        "db": "PubMed",
        "db_id": "28420982",
        "db_name": "Tau Oligomers: Cytotoxicity, Propagation, and Mitochondrial Damage.",
        "first": "Shafiei SS",
        "journal": "Frontiers in aging neuroscience",
        "last": "Castillo-Carranza DL",
        "pages": "83",
        "volume": "9"
      },
      "evidence": "In AD, tau pathology and neuronal cell loss coincide in the same brain regions, and as brain dysfunction progresses, NFTs are found in greater anatomical distributions (Ihara, 2001)",
      "key": "e4f5147c849c51b04e1ea8164884ef2d",
      "line": 65,
      "relation": "association",
      "source": 29,
      "target": 68
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        },
        "MeSHAnatomy": {
          "Cerebral Cortex": true
        },
        "PublicationType": {
          "Review": true
        }
      },
      "citation": {
        "authors": [
          "Castillo-Carranza DL",
          "Guerrero-Muñoz MJ",
          "Shafiei SS"
        ],
        "date": "2017-01-01",
        "db": "PubMed",
        "db_id": "28420982",
        "db_name": "Tau Oligomers: Cytotoxicity, Propagation, and Mitochondrial Damage.",
        "first": "Shafiei SS",
        "journal": "Frontiers in aging neuroscience",
        "last": "Castillo-Carranza DL",
        "pages": "83",
        "volume": "9"
      },
      "evidence": "Compared to non-demented controls, AD brains exhibit up to 50% of neuronal loss in the cortex, exceeding the number of NFTs (Gómez-Isla et al., 1997)",
      "key": "8bb8b511809b1b71a31dffbb350652aa",
      "line": 72,
      "relation": "positiveCorrelation",
      "source": 29,
      "target": 61
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        },
        "MeSHAnatomy": {
          "Cerebral Cortex": true
        },
        "PublicationType": {
          "Review": true
        }
      },
      "citation": {
        "authors": [
          "Castillo-Carranza DL",
          "Guerrero-Muñoz MJ",
          "Shafiei SS"
        ],
        "date": "2017-01-01",
        "db": "PubMed",
        "db_id": "28420982",
        "db_name": "Tau Oligomers: Cytotoxicity, Propagation, and Mitochondrial Damage.",
        "first": "Shafiei SS",
        "journal": "Frontiers in aging neuroscience",
        "last": "Castillo-Carranza DL",
        "pages": "83",
        "volume": "9"
      },
      "evidence": "Compared to non-demented controls, AD brains exhibit up to 50% of neuronal loss in the cortex, exceeding the number of NFTs (Gómez-Isla et al., 1997)",
      "key": "78261b9df9287ad14fb4585703152748",
      "line": 72,
      "relation": "positiveCorrelation",
      "source": 61,
      "target": 29
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        },
        "MeSHAnatomy": {
          "Cerebral Cortex": true
        },
        "PublicationType": {
          "Review": true
        }
      },
      "citation": {
        "authors": [
          "Castillo-Carranza DL",
          "Guerrero-Muñoz MJ",
          "Shafiei SS"
        ],
        "date": "2017-01-01",
        "db": "PubMed",
        "db_id": "28420982",
        "db_name": "Tau Oligomers: Cytotoxicity, Propagation, and Mitochondrial Damage.",
        "first": "Shafiei SS",
        "journal": "Frontiers in aging neuroscience",
        "last": "Castillo-Carranza DL",
        "pages": "83",
        "volume": "9"
      },
      "evidence": "Compared to non-demented controls, AD brains exhibit up to 50% of neuronal loss in the cortex, exceeding the number of NFTs (Gómez-Isla et al., 1997)",
      "key": "ba43d2e834c0894f0d030cd9333eaf2b",
      "line": 73,
      "relation": "positiveCorrelation",
      "source": 61,
      "target": 10
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        },
        "MeSHAnatomy": {
          "Cerebral Cortex": true
        },
        "PublicationType": {
          "Review": true
        }
      },
      "citation": {
        "authors": [
          "Castillo-Carranza DL",
          "Guerrero-Muñoz MJ",
          "Shafiei SS"
        ],
        "date": "2017-01-01",
        "db": "PubMed",
        "db_id": "28420982",
        "db_name": "Tau Oligomers: Cytotoxicity, Propagation, and Mitochondrial Damage.",
        "first": "Shafiei SS",
        "journal": "Frontiers in aging neuroscience",
        "last": "Castillo-Carranza DL",
        "pages": "83",
        "volume": "9"
      },
      "evidence": "The onset of clinical symptoms in AD and PSP brains correlate with elevated levels of tau oligomer (Maeda et al., 2006, 2007; Patterson et al., 2011; Lasagna-Reeves et al., 2012b; Gerson et al., 2014a)",
      "key": "ad74bd846c5db51dc1c5ecbd455deca6",
      "line": 141,
      "relation": "positiveCorrelation",
      "source": 61,
      "target": 5
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        },
        "MeSHAnatomy": {
          "Cerebrospinal Fluid": true
        },
        "PublicationType": {
          "Review": true
        }
      },
      "citation": {
        "authors": [
          "Castillo-Carranza DL",
          "Guerrero-Muñoz MJ",
          "Shafiei SS"
        ],
        "date": "2017-01-01",
        "db": "PubMed",
        "db_id": "28420982",
        "db_name": "Tau Oligomers: Cytotoxicity, Propagation, and Mitochondrial Damage.",
        "first": "Shafiei SS",
        "journal": "Frontiers in aging neuroscience",
        "last": "Castillo-Carranza DL",
        "pages": "83",
        "volume": "9"
      },
      "evidence": "In AD, the quantity of tau identified in the CSF increases with disease progression (Hampel et al., 2010). However, the mechanism of tau propagation from the brain to the CSF remains elusive",
      "key": "386f525f4125d5da621bc228a4cba573",
      "line": 207,
      "relation": "positiveCorrelation",
      "source": 61,
      "target": 54
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHAnatomy": {
          "Neocortex": true
        },
        "PublicationType": {
          "Review": true
        }
      },
      "citation": {
        "authors": [
          "Castillo-Carranza DL",
          "Guerrero-Muñoz MJ",
          "Shafiei SS"
        ],
        "date": "2017-01-01",
        "db": "PubMed",
        "db_id": "28420982",
        "db_name": "Tau Oligomers: Cytotoxicity, Propagation, and Mitochondrial Damage.",
        "first": "Shafiei SS",
        "journal": "Frontiers in aging neuroscience",
        "last": "Castillo-Carranza DL",
        "pages": "83",
        "volume": "9"
      },
      "evidence": "In AD, tau pathology has been found to spread from the transentorhinal cortex to the neocortex in a sequential pathway",
      "key": "f31d349525d117f0ac63b36871f64edd",
      "line": 240,
      "relation": "increases",
      "source": 61,
      "target": 54
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        },
        "MeSHAnatomy": {
          "Cerebrospinal Fluid": true
        },
        "MeSHDisease": {
          "Alzheimer Disease": true
        },
        "PublicationType": {
          "Review": true
        }
      },
      "citation": {
        "authors": [
          "Castillo-Carranza DL",
          "Guerrero-Muñoz MJ",
          "Shafiei SS"
        ],
        "date": "2017-01-01",
        "db": "PubMed",
        "db_id": "28420982",
        "db_name": "Tau Oligomers: Cytotoxicity, Propagation, and Mitochondrial Damage.",
        "first": "Shafiei SS",
        "journal": "Frontiers in aging neuroscience",
        "last": "Castillo-Carranza DL",
        "pages": "83",
        "volume": "9"
      },
      "evidence": "More recently, patients affected with FTD and AD, were found to have high levels of total tau and phosphorylated tau (p-T181 and p-S396; Saman et al., 2012)",
      "key": "9400b3d94b6b44b02f23c25b64660a16",
      "line": 271,
      "relation": "positiveCorrelation",
      "source": 61,
      "target": 54
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        },
        "MeSHAnatomy": {
          "Cerebrospinal Fluid": true
        },
        "MeSHDisease": {
          "Alzheimer Disease": true
        },
        "PublicationType": {
          "Review": true
        }
      },
      "citation": {
        "authors": [
          "Castillo-Carranza DL",
          "Guerrero-Muñoz MJ",
          "Shafiei SS"
        ],
        "date": "2017-01-01",
        "db": "PubMed",
        "db_id": "28420982",
        "db_name": "Tau Oligomers: Cytotoxicity, Propagation, and Mitochondrial Damage.",
        "first": "Shafiei SS",
        "journal": "Frontiers in aging neuroscience",
        "last": "Castillo-Carranza DL",
        "pages": "83",
        "volume": "9"
      },
      "evidence": "More recently, patients affected with FTD and AD, were found to have high levels of total tau and phosphorylated tau (p-T181 and p-S396; Saman et al., 2012)",
      "key": "ed908f4129a524e40f700085804bb7ee",
      "line": 272,
      "relation": "positiveCorrelation",
      "source": 61,
      "target": 58
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        },
        "MeSHAnatomy": {
          "Cerebrospinal Fluid": true
        },
        "MeSHDisease": {
          "Alzheimer Disease": true
        },
        "PublicationType": {
          "Review": true
        }
      },
      "citation": {
        "authors": [
          "Castillo-Carranza DL",
          "Guerrero-Muñoz MJ",
          "Shafiei SS"
        ],
        "date": "2017-01-01",
        "db": "PubMed",
        "db_id": "28420982",
        "db_name": "Tau Oligomers: Cytotoxicity, Propagation, and Mitochondrial Damage.",
        "first": "Shafiei SS",
        "journal": "Frontiers in aging neuroscience",
        "last": "Castillo-Carranza DL",
        "pages": "83",
        "volume": "9"
      },
      "evidence": "More recently, patients affected with FTD and AD, were found to have high levels of total tau and phosphorylated tau (p-T181 and p-S396; Saman et al., 2012)",
      "key": "347f752c9b573bf63eb4557f4db7142c",
      "line": 273,
      "relation": "positiveCorrelation",
      "source": 61,
      "target": 59
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        },
        "MeSHAnatomy": {
          "Extracellular Fluid": true
        },
        "PublicationType": {
          "Review": true
        }
      },
      "citation": {
        "authors": [
          "Castillo-Carranza DL",
          "Guerrero-Muñoz MJ",
          "Shafiei SS"
        ],
        "date": "2017-01-01",
        "db": "PubMed",
        "db_id": "28420982",
        "db_name": "Tau Oligomers: Cytotoxicity, Propagation, and Mitochondrial Damage.",
        "first": "Shafiei SS",
        "journal": "Frontiers in aging neuroscience",
        "last": "Castillo-Carranza DL",
        "pages": "83",
        "volume": "9"
      },
      "evidence": "Recently, tau was discovered in the interstitial fluid of awake, wild-type mice, suggesting its release by neurons in the absence of neurodegeneration (Yamada et al., 2011)",
      "key": "a57a752f3056f7c55441510871002633",
      "line": 215,
      "object": {
        "effect": {
          "fromLoc": {
            "name": "intracellular",
            "namespace": "bel"
          },
          "toLoc": {
            "name": "extracellular space",
            "namespace": "bel"
          }
        },
        "modifier": "Translocation"
      },
      "relation": "decreases",
      "source": 36,
      "target": 54
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        },
        "MeSHAnatomy": {
          "Cerebral Cortex": true
        },
        "PublicationType": {
          "Review": true
        }
      },
      "citation": {
        "authors": [
          "Castillo-Carranza DL",
          "Guerrero-Muñoz MJ",
          "Shafiei SS"
        ],
        "date": "2017-01-01",
        "db": "PubMed",
        "db_id": "28420982",
        "db_name": "Tau Oligomers: Cytotoxicity, Propagation, and Mitochondrial Damage.",
        "first": "Shafiei SS",
        "journal": "Frontiers in aging neuroscience",
        "last": "Castillo-Carranza DL",
        "pages": "83",
        "volume": "9"
      },
      "evidence": "While evidence has linked FTD with parkinsonism in patients to tau mutations on chromosome 17 (FTDP-17), implying that tau dysfunction alone can cause neurodegeneration (Reed et al., 2001), studies in animal models have shown that overexpression of tau can lead to cell death (Lee et al., 2001; Tanemura et al., 2001, 2002; Tatebayashi et al., 2002) and exhibit behavioral abnormalities and synaptic dysfunction without the presence of NFTs (Wittmann et al., 2001; Andorfer et al., 2003; Santacruz et al., 2005; Spires et al., 2006; Berger et al., 2007; Yoshiyama et al., 2007; Cowan et al., 2010)",
      "key": "30c0b29fecef44826d1078886536bc7a",
      "line": 89,
      "relation": "association",
      "source": 31,
      "target": 54
    },
    {
      "annotations": {
        "Confidence": {
          "Low": true
        },
        "MeSHAnatomy": {
          "Cerebral Cortex": true
        },
        "PublicationType": {
          "Review": true
        }
      },
      "citation": {
        "authors": [
          "Castillo-Carranza DL",
          "Guerrero-Muñoz MJ",
          "Shafiei SS"
        ],
        "date": "2017-01-01",
        "db": "PubMed",
        "db_id": "28420982",
        "db_name": "Tau Oligomers: Cytotoxicity, Propagation, and Mitochondrial Damage.",
        "first": "Shafiei SS",
        "journal": "Frontiers in aging neuroscience",
        "last": "Castillo-Carranza DL",
        "pages": "83",
        "volume": "9"
      },
      "evidence": "While evidence indicates that these deposits are not toxic, many studies suggest that the tau oligomer, an intermediate entity, is likely responsible for disease onset",
      "key": "a50f7b453874711acd3a151ed6d93405",
      "line": 97,
      "relation": "increases",
      "source": 5,
      "target": 67
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHAnatomy": {
          "Cerebral Cortex": true
        },
        "PublicationType": {
          "Review": true
        }
      },
      "citation": {
        "authors": [
          "Castillo-Carranza DL",
          "Guerrero-Muñoz MJ",
          "Shafiei SS"
        ],
        "date": "2017-01-01",
        "db": "PubMed",
        "db_id": "28420982",
        "db_name": "Tau Oligomers: Cytotoxicity, Propagation, and Mitochondrial Damage.",
        "first": "Shafiei SS",
        "journal": "Frontiers in aging neuroscience",
        "last": "Castillo-Carranza DL",
        "pages": "83",
        "volume": "9"
      },
      "evidence": "These tau oligomers potentiate neuronal damage, leading to neurodegeneration and traumatic brain injury (Hawkins et al., 2013; Gerson et al., 2014a, 2016; Sengupta et al., 2015). Moreover, they have been implicated in synaptic loss as shown in studies of wild-type human tau transgenic mice (Spires et al., 2006; Berger et al., 2007; Clavaguera et al., 2013)",
      "key": "a0ecefcf6af38f943113bf315b98e3b7",
      "line": 119,
      "relation": "increases",
      "source": 5,
      "target": 36
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        },
        "MeSHAnatomy": {
          "Hippocampus": true
        },
        "PublicationType": {
          "Review": true
        }
      },
      "citation": {
        "authors": [
          "Castillo-Carranza DL",
          "Guerrero-Muñoz MJ",
          "Shafiei SS"
        ],
        "date": "2017-01-01",
        "db": "PubMed",
        "db_id": "28420982",
        "db_name": "Tau Oligomers: Cytotoxicity, Propagation, and Mitochondrial Damage.",
        "first": "Shafiei SS",
        "journal": "Frontiers in aging neuroscience",
        "last": "Castillo-Carranza DL",
        "pages": "83",
        "volume": "9"
      },
      "evidence": "These studies demonstrate that tau oligomers may be the toxic entities responsible for neurodegeneration in tauopathies (Ward et al., 2012",
      "key": "4a548e775f907c8a9089a2b4319775ed",
      "line": 188,
      "relation": "increases",
      "source": 5,
      "target": 36
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHAnatomy": {
          "Cerebral Cortex": true
        },
        "PublicationType": {
          "Review": true
        }
      },
      "citation": {
        "authors": [
          "Castillo-Carranza DL",
          "Guerrero-Muñoz MJ",
          "Shafiei SS"
        ],
        "date": "2017-01-01",
        "db": "PubMed",
        "db_id": "28420982",
        "db_name": "Tau Oligomers: Cytotoxicity, Propagation, and Mitochondrial Damage.",
        "first": "Shafiei SS",
        "journal": "Frontiers in aging neuroscience",
        "last": "Castillo-Carranza DL",
        "pages": "83",
        "volume": "9"
      },
      "evidence": "These tau oligomers potentiate neuronal damage, leading to neurodegeneration and traumatic brain injury (Hawkins et al., 2013; Gerson et al., 2014a, 2016; Sengupta et al., 2015). Moreover, they have been implicated in synaptic loss as shown in studies of wild-type human tau transgenic mice (Spires et al., 2006; Berger et al., 2007; Clavaguera et al., 2013)",
      "key": "ed08f33effbef1085054d02d2802b599",
      "line": 120,
      "relation": "increases",
      "source": 5,
      "target": 62
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHAnatomy": {
          "Cerebral Cortex": true
        },
        "PublicationType": {
          "Review": true
        }
      },
      "citation": {
        "authors": [
          "Castillo-Carranza DL",
          "Guerrero-Muñoz MJ",
          "Shafiei SS"
        ],
        "date": "2017-01-01",
        "db": "PubMed",
        "db_id": "28420982",
        "db_name": "Tau Oligomers: Cytotoxicity, Propagation, and Mitochondrial Damage.",
        "first": "Shafiei SS",
        "journal": "Frontiers in aging neuroscience",
        "last": "Castillo-Carranza DL",
        "pages": "83",
        "volume": "9"
      },
      "evidence": "These tau oligomers potentiate neuronal damage, leading to neurodegeneration and traumatic brain injury (Hawkins et al., 2013; Gerson et al., 2014a, 2016; Sengupta et al., 2015). Moreover, they have been implicated in synaptic loss as shown in studies of wild-type human tau transgenic mice (Spires et al., 2006; Berger et al., 2007; Clavaguera et al., 2013)",
      "key": "8f7c1544f82ed182ff2ded68ad1bff9f",
      "line": 121,
      "relation": "decreases",
      "source": 5,
      "target": 13
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        },
        "MeSHAnatomy": {
          "Cerebral Cortex": true
        },
        "PublicationType": {
          "Review": true
        }
      },
      "citation": {
        "authors": [
          "Castillo-Carranza DL",
          "Guerrero-Muñoz MJ",
          "Shafiei SS"
        ],
        "date": "2017-01-01",
        "db": "PubMed",
        "db_id": "28420982",
        "db_name": "Tau Oligomers: Cytotoxicity, Propagation, and Mitochondrial Damage.",
        "first": "Shafiei SS",
        "journal": "Frontiers in aging neuroscience",
        "last": "Castillo-Carranza DL",
        "pages": "83",
        "volume": "9"
      },
      "evidence": "When the oligomer lengthens, it adapts a beta-sheet structure and transforms into a detergent-insoluble aggregate with granular appearance under Atomic Force Microscopy (AFM)",
      "key": "f78edd68b72075878c161779a8b5bbd1",
      "line": 128,
      "relation": "increases",
      "source": 5,
      "target": 8
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        },
        "MeSHAnatomy": {
          "Cerebral Cortex": true
        },
        "PublicationType": {
          "Review": true
        }
      },
      "citation": {
        "authors": [
          "Castillo-Carranza DL",
          "Guerrero-Muñoz MJ",
          "Shafiei SS"
        ],
        "date": "2017-01-01",
        "db": "PubMed",
        "db_id": "28420982",
        "db_name": "Tau Oligomers: Cytotoxicity, Propagation, and Mitochondrial Damage.",
        "first": "Shafiei SS",
        "journal": "Frontiers in aging neuroscience",
        "last": "Castillo-Carranza DL",
        "pages": "83",
        "volume": "9"
      },
      "evidence": "The onset of clinical symptoms in AD and PSP brains correlate with elevated levels of tau oligomer (Maeda et al., 2006, 2007; Patterson et al., 2011; Lasagna-Reeves et al., 2012b; Gerson et al., 2014a)",
      "key": "42581db7472c7e0a7a063ea976f670b5",
      "line": 141,
      "relation": "positiveCorrelation",
      "source": 5,
      "target": 61
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        },
        "MeSHAnatomy": {
          "Cerebral Cortex": true
        },
        "PublicationType": {
          "Review": true
        }
      },
      "citation": {
        "authors": [
          "Castillo-Carranza DL",
          "Guerrero-Muñoz MJ",
          "Shafiei SS"
        ],
        "date": "2017-01-01",
        "db": "PubMed",
        "db_id": "28420982",
        "db_name": "Tau Oligomers: Cytotoxicity, Propagation, and Mitochondrial Damage.",
        "first": "Shafiei SS",
        "journal": "Frontiers in aging neuroscience",
        "last": "Castillo-Carranza DL",
        "pages": "83",
        "volume": "9"
      },
      "evidence": "The onset of clinical symptoms in AD and PSP brains correlate with elevated levels of tau oligomer (Maeda et al., 2006, 2007; Patterson et al., 2011; Lasagna-Reeves et al., 2012b; Gerson et al., 2014a)",
      "key": "dc3a98eac004f00dce4f8956e2fca7b0",
      "line": 142,
      "relation": "positiveCorrelation",
      "source": 5,
      "target": 66
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHAnatomy": {
          "Cerebral Cortex": true
        },
        "PublicationType": {
          "Review": true
        }
      },
      "citation": {
        "authors": [
          "Castillo-Carranza DL",
          "Guerrero-Muñoz MJ",
          "Shafiei SS"
        ],
        "date": "2017-01-01",
        "db": "PubMed",
        "db_id": "28420982",
        "db_name": "Tau Oligomers: Cytotoxicity, Propagation, and Mitochondrial Damage.",
        "first": "Shafiei SS",
        "journal": "Frontiers in aging neuroscience",
        "last": "Castillo-Carranza DL",
        "pages": "83",
        "volume": "9"
      },
      "evidence": "When tau oligomers, rather than tau monomers or fibrils, are injected into the brain of wild-type mice, cognitive, synaptic, and mitochondrial abnormalities follow (Lasagna- Reeves et al., 2011; Castillo-Carranza et al., 2014b)",
      "key": "c9d28862173379b8b742cde34d81f151",
      "line": 149,
      "relation": "decreases",
      "source": 5,
      "target": 32
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHAnatomy": {
          "Cerebral Cortex": true
        },
        "PublicationType": {
          "Review": true
        }
      },
      "citation": {
        "authors": [
          "Castillo-Carranza DL",
          "Guerrero-Muñoz MJ",
          "Shafiei SS"
        ],
        "date": "2017-01-01",
        "db": "PubMed",
        "db_id": "28420982",
        "db_name": "Tau Oligomers: Cytotoxicity, Propagation, and Mitochondrial Damage.",
        "first": "Shafiei SS",
        "journal": "Frontiers in aging neuroscience",
        "last": "Castillo-Carranza DL",
        "pages": "83",
        "volume": "9"
      },
      "evidence": "When tau oligomers, rather than tau monomers or fibrils, are injected into the brain of wild-type mice, cognitive, synaptic, and mitochondrial abnormalities follow (Lasagna- Reeves et al., 2011; Castillo-Carranza et al., 2014b)",
      "key": "ac6e0945c2cad180e959e930540791d0",
      "line": 150,
      "relation": "decreases",
      "source": 5,
      "target": 27
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHAnatomy": {
          "Cerebral Cortex": true
        },
        "PublicationType": {
          "Review": true
        }
      },
      "citation": {
        "authors": [
          "Castillo-Carranza DL",
          "Guerrero-Muñoz MJ",
          "Shafiei SS"
        ],
        "date": "2017-01-01",
        "db": "PubMed",
        "db_id": "28420982",
        "db_name": "Tau Oligomers: Cytotoxicity, Propagation, and Mitochondrial Damage.",
        "first": "Shafiei SS",
        "journal": "Frontiers in aging neuroscience",
        "last": "Castillo-Carranza DL",
        "pages": "83",
        "volume": "9"
      },
      "evidence": "When tau oligomers, rather than tau monomers or fibrils, are injected into the brain of wild-type mice, cognitive, synaptic, and mitochondrial abnormalities follow (Lasagna- Reeves et al., 2011; Castillo-Carranza et al., 2014b)",
      "key": "59529c047feb93533e29630cb8161675",
      "line": 151,
      "relation": "decreases",
      "source": 5,
      "target": 26
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHAnatomy": {
          "Cerebral Cortex": true
        },
        "PublicationType": {
          "Review": true
        }
      },
      "citation": {
        "authors": [
          "Castillo-Carranza DL",
          "Guerrero-Muñoz MJ",
          "Shafiei SS"
        ],
        "date": "2017-01-01",
        "db": "PubMed",
        "db_id": "28420982",
        "db_name": "Tau Oligomers: Cytotoxicity, Propagation, and Mitochondrial Damage.",
        "first": "Shafiei SS",
        "journal": "Frontiers in aging neuroscience",
        "last": "Castillo-Carranza DL",
        "pages": "83",
        "volume": "9"
      },
      "evidence": "This indicates that tauopathies progress via a prion-like mechanism dependent upon tau oligomers (Gerson and Kayed, 2013; Castillo-Carranza et al., 2014b)",
      "key": "7841f71e5ace2b0662107f4b122b91f7",
      "line": 165,
      "relation": "increases",
      "source": 5,
      "target": 68
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        },
        "MeSHAnatomy": {
          "Hippocampus": true
        },
        "PublicationType": {
          "Review": true
        }
      },
      "citation": {
        "authors": [
          "Castillo-Carranza DL",
          "Guerrero-Muñoz MJ",
          "Shafiei SS"
        ],
        "date": "2017-01-01",
        "db": "PubMed",
        "db_id": "28420982",
        "db_name": "Tau Oligomers: Cytotoxicity, Propagation, and Mitochondrial Damage.",
        "first": "Shafiei SS",
        "journal": "Frontiers in aging neuroscience",
        "last": "Castillo-Carranza DL",
        "pages": "83",
        "volume": "9"
      },
      "evidence": "These studies demonstrate that tau oligomers may be the toxic entities responsible for neurodegeneration in tauopathies (Ward et al., 2012",
      "key": "6701b5677f7529c40677359caa9f117f",
      "line": 187,
      "relation": "increases",
      "source": 5,
      "target": 68
    },
    {
      "annotations": {
        "Confidence": {
          "Low": true
        },
        "MeSHAnatomy": {
          "Cerebral Cortex": true
        },
        "PublicationType": {
          "Review": true
        }
      },
      "citation": {
        "authors": [
          "Castillo-Carranza DL",
          "Guerrero-Muñoz MJ",
          "Shafiei SS"
        ],
        "date": "2017-01-01",
        "db": "PubMed",
        "db_id": "28420982",
        "db_name": "Tau Oligomers: Cytotoxicity, Propagation, and Mitochondrial Damage.",
        "first": "Shafiei SS",
        "journal": "Frontiers in aging neuroscience",
        "last": "Castillo-Carranza DL",
        "pages": "83",
        "volume": "9"
      },
      "evidence": "With this concept, tau may be able to translocate between neurons and augment toxic tau components; in fact, evidence suggests probability of tau oligomer propagation between synaptically connected neurons (Gendreau and Hall, 2013; Pooler et al., 2013b)",
      "key": "50758a8c0ddb0ae8f39fc2dc44faa6ed",
      "line": 173,
      "object": {
        "effect": {
          "fromLoc": {
            "name": "neuron part",
            "namespace": "GO"
          },
          "toLoc": {
            "name": "neuron part",
            "namespace": "GO"
          }
        },
        "modifier": "Translocation"
      },
      "relation": "increases",
      "source": 5,
      "target": 54
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        },
        "MeSHAnatomy": {
          "Hippocampus": true
        },
        "PublicationType": {
          "Review": true
        }
      },
      "citation": {
        "authors": [
          "Castillo-Carranza DL",
          "Guerrero-Muñoz MJ",
          "Shafiei SS"
        ],
        "date": "2017-01-01",
        "db": "PubMed",
        "db_id": "28420982",
        "db_name": "Tau Oligomers: Cytotoxicity, Propagation, and Mitochondrial Damage.",
        "first": "Shafiei SS",
        "journal": "Frontiers in aging neuroscience",
        "last": "Castillo-Carranza DL",
        "pages": "83",
        "volume": "9"
      },
      "evidence": "Further, mice injected with tau oligomers in the proximity of the hippocampus experienced immediate memory impairment (Lasagna-Reeves et al., 2011)",
      "key": "42d34c5f22c8be7ce3899b92299ada3f",
      "line": 181,
      "relation": "decreases",
      "source": 5,
      "target": 35
    },
    {
      "annotations": {
        "CellStructure": {
          "Extracellular Space": true
        },
        "Confidence": {
          "High": true
        },
        "MeSHAnatomy": {
          "Neurons": true
        },
        "MeSHDisease": {
          "Alzheimer Disease": true
        },
        "PublicationType": {
          "Review": true
        }
      },
      "citation": {
        "authors": [
          "Castillo-Carranza DL",
          "Guerrero-Muñoz MJ",
          "Shafiei SS"
        ],
        "date": "2017-01-01",
        "db": "PubMed",
        "db_id": "28420982",
        "db_name": "Tau Oligomers: Cytotoxicity, Propagation, and Mitochondrial Damage.",
        "first": "Shafiei SS",
        "journal": "Frontiers in aging neuroscience",
        "last": "Castillo-Carranza DL",
        "pages": "83",
        "volume": "9"
      },
      "evidence": "The study discovered that APFs form after tau oligomer formation and bypass higher NFT aggregate formation",
      "key": "1c9d046c892ba2f16d9dd0d3204eb7dc",
      "line": 385,
      "relation": "increases",
      "source": 5,
      "target": 3
    },
    {
      "annotations": {
        "CellStructure": {
          "Extracellular Space": true
        },
        "Confidence": {
          "High": true
        },
        "MeSHAnatomy": {
          "Neurons": true
        },
        "MeSHDisease": {
          "Alzheimer Disease": true
        },
        "PublicationType": {
          "Review": true
        }
      },
      "citation": {
        "authors": [
          "Castillo-Carranza DL",
          "Guerrero-Muñoz MJ",
          "Shafiei SS"
        ],
        "date": "2017-01-01",
        "db": "PubMed",
        "db_id": "28420982",
        "db_name": "Tau Oligomers: Cytotoxicity, Propagation, and Mitochondrial Damage.",
        "first": "Shafiei SS",
        "journal": "Frontiers in aging neuroscience",
        "last": "Castillo-Carranza DL",
        "pages": "83",
        "volume": "9"
      },
      "evidence": "Oligomeric tau intermediates decrease cell viability (Flach et al., 2012)",
      "key": "256e29868ce2128f0f4c9c3ed1df71df",
      "line": 396,
      "relation": "decreases",
      "source": 5,
      "target": 37
    },
    {
      "annotations": {
        "CellStructure": {
          "Extracellular Space": true
        },
        "Confidence": {
          "High": true
        },
        "MeSHAnatomy": {
          "Neurons": true
        },
        "MeSHDisease": {
          "Alzheimer Disease": true
        },
        "PublicationType": {
          "Review": true
        }
      },
      "citation": {
        "authors": [
          "Castillo-Carranza DL",
          "Guerrero-Muñoz MJ",
          "Shafiei SS"
        ],
        "date": "2017-01-01",
        "db": "PubMed",
        "db_id": "28420982",
        "db_name": "Tau Oligomers: Cytotoxicity, Propagation, and Mitochondrial Damage.",
        "first": "Shafiei SS",
        "journal": "Frontiers in aging neuroscience",
        "last": "Castillo-Carranza DL",
        "pages": "83",
        "volume": "9"
      },
      "evidence": "Recently, data has shown that injected tau oligomers colocalize with the mitochondrial marker porin, suggesting a pathological relationship",
      "key": "8eb2dd83dc118cf4ed22b935d9f282e1",
      "line": 418,
      "relation": "association",
      "source": 5,
      "target": 60
    },
    {
      "annotations": {
        "CellStructure": {
          "Extracellular Space": true
        },
        "Confidence": {
          "High": true
        },
        "MeSHAnatomy": {
          "Neurons": true
        },
        "MeSHDisease": {
          "Alzheimer Disease": true
        },
        "PublicationType": {
          "Review": true
        }
      },
      "citation": {
        "authors": [
          "Castillo-Carranza DL",
          "Guerrero-Muñoz MJ",
          "Shafiei SS"
        ],
        "date": "2017-01-01",
        "db": "PubMed",
        "db_id": "28420982",
        "db_name": "Tau Oligomers: Cytotoxicity, Propagation, and Mitochondrial Damage.",
        "first": "Shafiei SS",
        "journal": "Frontiers in aging neuroscience",
        "last": "Castillo-Carranza DL",
        "pages": "83",
        "volume": "9"
      },
      "evidence": "In fact, tau oligomers might disrupt microtubule stability and trafficking, thus affecting organelle distribution",
      "key": "b6cc3cb9dc31139d3bb4db5af115bf5b",
      "line": 424,
      "object": {
        "modifier": "Activity"
      },
      "relation": "decreases",
      "source": 5,
      "target": 11
    },
    {
      "annotations": {
        "CellStructure": {
          "Extracellular Space": true
        },
        "Confidence": {
          "High": true
        },
        "MeSHAnatomy": {
          "Neurons": true
        },
        "MeSHDisease": {
          "Alzheimer Disease": true
        },
        "PublicationType": {
          "Review": true
        }
      },
      "citation": {
        "authors": [
          "Castillo-Carranza DL",
          "Guerrero-Muñoz MJ",
          "Shafiei SS"
        ],
        "date": "2017-01-01",
        "db": "PubMed",
        "db_id": "28420982",
        "db_name": "Tau Oligomers: Cytotoxicity, Propagation, and Mitochondrial Damage.",
        "first": "Shafiei SS",
        "journal": "Frontiers in aging neuroscience",
        "last": "Castillo-Carranza DL",
        "pages": "83",
        "volume": "9"
      },
      "evidence": "Also, data shows low levels of complex I in brain hemispheres injected with tau oligomers when compared to brains injected with monomers or fibrils",
      "key": "2288d1f154e547d07282e92864a14950",
      "line": 430,
      "relation": "decreases",
      "source": 5,
      "target": 16
    },
    {
      "annotations": {
        "CellStructure": {
          "Extracellular Space": true
        },
        "Confidence": {
          "High": true
        },
        "MeSHAnatomy": {
          "Neurons": true
        },
        "MeSHDisease": {
          "Alzheimer Disease": true
        },
        "PublicationType": {
          "Review": true
        }
      },
      "citation": {
        "authors": [
          "Castillo-Carranza DL",
          "Guerrero-Muñoz MJ",
          "Shafiei SS"
        ],
        "date": "2017-01-01",
        "db": "PubMed",
        "db_id": "28420982",
        "db_name": "Tau Oligomers: Cytotoxicity, Propagation, and Mitochondrial Damage.",
        "first": "Shafiei SS",
        "journal": "Frontiers in aging neuroscience",
        "last": "Castillo-Carranza DL",
        "pages": "83",
        "volume": "9"
      },
      "evidence": "These results imply that tau oligomers initially affect complex I activity and may directly or indirectly disturb the later stage of complex V ATP synthesis (Lasagna-Reeves et al., 2011)",
      "key": "f0bf41968726c00199431b6fb654ea4a",
      "line": 437,
      "object": {
        "modifier": "Activity"
      },
      "relation": "decreases",
      "source": 5,
      "target": 16
    },
    {
      "annotations": {
        "CellStructure": {
          "Extracellular Space": true
        },
        "Confidence": {
          "High": true
        },
        "MeSHAnatomy": {
          "Neurons": true
        },
        "MeSHDisease": {
          "Alzheimer Disease": true
        },
        "PublicationType": {
          "Review": true
        }
      },
      "citation": {
        "authors": [
          "Castillo-Carranza DL",
          "Guerrero-Muñoz MJ",
          "Shafiei SS"
        ],
        "date": "2017-01-01",
        "db": "PubMed",
        "db_id": "28420982",
        "db_name": "Tau Oligomers: Cytotoxicity, Propagation, and Mitochondrial Damage.",
        "first": "Shafiei SS",
        "journal": "Frontiers in aging neuroscience",
        "last": "Castillo-Carranza DL",
        "pages": "83",
        "volume": "9"
      },
      "evidence": "These results imply that tau oligomers initially affect complex I activity and may directly or indirectly disturb the later stage of complex V ATP synthesis (Lasagna-Reeves et al., 2011)",
      "key": "b5b02bb42b17fcd5de22f10b0884f1eb",
      "line": 438,
      "relation": "decreases",
      "source": 5,
      "target": 20
    },
    {
      "annotations": {
        "CellStructure": {
          "Extracellular Space": true
        },
        "Confidence": {
          "High": true
        },
        "MeSHAnatomy": {
          "Neurons": true
        },
        "MeSHDisease": {
          "Alzheimer Disease": true
        },
        "PublicationType": {
          "Review": true
        }
      },
      "citation": {
        "authors": [
          "Castillo-Carranza DL",
          "Guerrero-Muñoz MJ",
          "Shafiei SS"
        ],
        "date": "2017-01-01",
        "db": "PubMed",
        "db_id": "28420982",
        "db_name": "Tau Oligomers: Cytotoxicity, Propagation, and Mitochondrial Damage.",
        "first": "Shafiei SS",
        "journal": "Frontiers in aging neuroscience",
        "last": "Castillo-Carranza DL",
        "pages": "83",
        "volume": "9"
      },
      "evidence": "Hemispheres injected with tau oligomers were found to have increased levels of caspase-9 activation (Lasagna-Reeves et al., 2011)",
      "key": "b751ffd750e08d0814ff97c93a626eb2",
      "line": 444,
      "object": {
        "modifier": "Activity"
      },
      "relation": "increases",
      "source": 5,
      "target": 49
    },
    {
      "annotations": {
        "CellStructure": {
          "Mitochondrial Membranes": true
        },
        "Confidence": {
          "Medium": true
        },
        "MeSHAnatomy": {
          "Neurons": true
        },
        "MeSHDisease": {
          "Alzheimer Disease": true
        },
        "PublicationType": {
          "Review": true
        }
      },
      "citation": {
        "authors": [
          "Castillo-Carranza DL",
          "Guerrero-Muñoz MJ",
          "Shafiei SS"
        ],
        "date": "2017-01-01",
        "db": "PubMed",
        "db_id": "28420982",
        "db_name": "Tau Oligomers: Cytotoxicity, Propagation, and Mitochondrial Damage.",
        "first": "Shafiei SS",
        "journal": "Frontiers in aging neuroscience",
        "last": "Castillo-Carranza DL",
        "pages": "83",
        "volume": "9"
      },
      "evidence": "Suggestively, as tau oligomers concentrate at the mitochondrial membrane, cytochrome C is released, leading to caspase-9 activation via a complex with apoptotic-peptidase activating- factor-1 (Apaf-1; Li et al., 1997)",
      "key": "069693d8efa46560056d5d334679aedf",
      "line": 452,
      "object": {
        "effect": {
          "fromLoc": {
            "name": "intracellular",
            "namespace": "bel"
          },
          "toLoc": {
            "name": "extracellular space",
            "namespace": "bel"
          }
        },
        "modifier": "Translocation"
      },
      "relation": "increases",
      "source": 5,
      "target": 52
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHAnatomy": {
          "Cerebral Cortex": true
        },
        "PublicationType": {
          "Review": true
        }
      },
      "citation": {
        "authors": [
          "Castillo-Carranza DL",
          "Guerrero-Muñoz MJ",
          "Shafiei SS"
        ],
        "date": "2017-01-01",
        "db": "PubMed",
        "db_id": "28420982",
        "db_name": "Tau Oligomers: Cytotoxicity, Propagation, and Mitochondrial Damage.",
        "first": "Shafiei SS",
        "journal": "Frontiers in aging neuroscience",
        "last": "Castillo-Carranza DL",
        "pages": "83",
        "volume": "9"
      },
      "evidence": "Hyper-phosphorylated tau assembles into small aggregates known as tau oligomers in route of NFT formation",
      "key": "362fa9c2c37ed983eb3d0648095253d0",
      "line": 102,
      "relation": "increases",
      "source": 57,
      "target": 5
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHAnatomy": {
          "Cerebral Cortex": true
        },
        "PublicationType": {
          "Review": true
        }
      },
      "citation": {
        "authors": [
          "Castillo-Carranza DL",
          "Guerrero-Muñoz MJ",
          "Shafiei SS"
        ],
        "date": "2017-01-01",
        "db": "PubMed",
        "db_id": "28420982",
        "db_name": "Tau Oligomers: Cytotoxicity, Propagation, and Mitochondrial Damage.",
        "first": "Shafiei SS",
        "journal": "Frontiers in aging neuroscience",
        "last": "Castillo-Carranza DL",
        "pages": "83",
        "volume": "9"
      },
      "evidence": "As hyperphosphorylated tau dislodges from microtubules, its affinity for other tau monomers leads individual tau to bind each other, forming oligomeric tau, a detergent-soluble aggregate",
      "key": "0ba618cfbfbdbe7ad60bc39538aea8b3",
      "line": 110,
      "relation": "increases",
      "source": 57,
      "target": 5
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHAnatomy": {
          "Cerebral Cortex": true
        },
        "PublicationType": {
          "Review": true
        }
      },
      "citation": {
        "authors": [
          "Castillo-Carranza DL",
          "Guerrero-Muñoz MJ",
          "Shafiei SS"
        ],
        "date": "2017-01-01",
        "db": "PubMed",
        "db_id": "28420982",
        "db_name": "Tau Oligomers: Cytotoxicity, Propagation, and Mitochondrial Damage.",
        "first": "Shafiei SS",
        "journal": "Frontiers in aging neuroscience",
        "last": "Castillo-Carranza DL",
        "pages": "83",
        "volume": "9"
      },
      "evidence": "Hyper-phosphorylated tau assembles into small aggregates known as tau oligomers in route of NFT formation",
      "key": "f45de4489529a7054cd967931e025544",
      "line": 103,
      "relation": "increases",
      "source": 57,
      "target": 10
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        },
        "MeSHAnatomy": {
          "Cerebral Cortex": true
        },
        "PublicationType": {
          "Review": true
        }
      },
      "citation": {
        "authors": [
          "Castillo-Carranza DL",
          "Guerrero-Muñoz MJ",
          "Shafiei SS"
        ],
        "date": "2017-01-01",
        "db": "PubMed",
        "db_id": "28420982",
        "db_name": "Tau Oligomers: Cytotoxicity, Propagation, and Mitochondrial Damage.",
        "first": "Shafiei SS",
        "journal": "Frontiers in aging neuroscience",
        "last": "Castillo-Carranza DL",
        "pages": "83",
        "volume": "9"
      },
      "evidence": "As these granular tau oligomers fuse together, they form tau fibrils, which ultimately form NFTs (Takashima, 2013)",
      "key": "16bcabbd93bb1d2c299148a75f6f0d8e",
      "line": 133,
      "relation": "increases",
      "source": 8,
      "target": 4
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        },
        "MeSHAnatomy": {
          "Cerebral Cortex": true
        },
        "PublicationType": {
          "Review": true
        }
      },
      "citation": {
        "authors": [
          "Castillo-Carranza DL",
          "Guerrero-Muñoz MJ",
          "Shafiei SS"
        ],
        "date": "2017-01-01",
        "db": "PubMed",
        "db_id": "28420982",
        "db_name": "Tau Oligomers: Cytotoxicity, Propagation, and Mitochondrial Damage.",
        "first": "Shafiei SS",
        "journal": "Frontiers in aging neuroscience",
        "last": "Castillo-Carranza DL",
        "pages": "83",
        "volume": "9"
      },
      "evidence": "As these granular tau oligomers fuse together, they form tau fibrils, which ultimately form NFTs (Takashima, 2013)",
      "key": "7d6fe0a9ecd42530cf78d308d83ff1c2",
      "line": 134,
      "relation": "increases",
      "source": 4,
      "target": 10
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        },
        "MeSHAnatomy": {
          "Cerebral Cortex": true
        },
        "PublicationType": {
          "Review": true
        }
      },
      "citation": {
        "authors": [
          "Castillo-Carranza DL",
          "Guerrero-Muñoz MJ",
          "Shafiei SS"
        ],
        "date": "2017-01-01",
        "db": "PubMed",
        "db_id": "28420982",
        "db_name": "Tau Oligomers: Cytotoxicity, Propagation, and Mitochondrial Damage.",
        "first": "Shafiei SS",
        "journal": "Frontiers in aging neuroscience",
        "last": "Castillo-Carranza DL",
        "pages": "83",
        "volume": "9"
      },
      "evidence": "The onset of clinical symptoms in AD and PSP brains correlate with elevated levels of tau oligomer (Maeda et al., 2006, 2007; Patterson et al., 2011; Lasagna-Reeves et al., 2012b; Gerson et al., 2014a)",
      "key": "4506727d7923a0059e5e67cc18b411d4",
      "line": 142,
      "relation": "positiveCorrelation",
      "source": 66,
      "target": 5
    },
    {
      "annotations": {
        "CellStructure": {
          "Extracellular Space": true
        },
        "Confidence": {
          "Medium": true
        },
        "MeSHAnatomy": {
          "Neurons": true
        },
        "MeSHDisease": {
          "Alzheimer Disease": true
        },
        "PublicationType": {
          "Review": true
        }
      },
      "citation": {
        "authors": [
          "Castillo-Carranza DL",
          "Guerrero-Muñoz MJ",
          "Shafiei SS"
        ],
        "date": "2017-01-01",
        "db": "PubMed",
        "db_id": "28420982",
        "db_name": "Tau Oligomers: Cytotoxicity, Propagation, and Mitochondrial Damage.",
        "first": "Shafiei SS",
        "journal": "Frontiers in aging neuroscience",
        "last": "Castillo-Carranza DL",
        "pages": "83",
        "volume": "9"
      },
      "evidence": "In aging, a protein involved in mitochondrial fission, dynamin-related protein 1 (DRP1), can bind tau abnormally, inducing neurodegeneration via mitochondrial dysfunction (Figure 2; DuBoff et al., 2012)",
      "key": "bfa9840b469a969fef02784ef4f604c9",
      "line": 404,
      "relation": "decreases",
      "source": 27,
      "target": 36
    },
    {
      "key": "1da5c19cb96491516b8536aecfdd6933",
      "relation": "partOf",
      "source": 18,
      "target": 43
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        },
        "MeSHAnatomy": {
          "Hippocampus": true
        },
        "PublicationType": {
          "Review": true
        }
      },
      "citation": {
        "authors": [
          "Castillo-Carranza DL",
          "Guerrero-Muñoz MJ",
          "Shafiei SS"
        ],
        "date": "2017-01-01",
        "db": "PubMed",
        "db_id": "28420982",
        "db_name": "Tau Oligomers: Cytotoxicity, Propagation, and Mitochondrial Damage.",
        "first": "Shafiei SS",
        "journal": "Frontiers in aging neuroscience",
        "last": "Castillo-Carranza DL",
        "pages": "83",
        "volume": "9"
      },
      "evidence": "This hints that tau plays a role in monitoring intracellular signaling pathways (Pooler and Hanger, 2010)",
      "key": "ed3bd7f543bc966860b2cd91df3c9bb6",
      "line": 199,
      "relation": "association",
      "source": 25,
      "target": 54
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        },
        "MeSHAnatomy": {
          "Entorhinal Cortex": true
        },
        "PublicationType": {
          "Review": true
        }
      },
      "citation": {
        "authors": [
          "Castillo-Carranza DL",
          "Guerrero-Muñoz MJ",
          "Shafiei SS"
        ],
        "date": "2017-01-01",
        "db": "PubMed",
        "db_id": "28420982",
        "db_name": "Tau Oligomers: Cytotoxicity, Propagation, and Mitochondrial Damage.",
        "first": "Shafiei SS",
        "journal": "Frontiers in aging neuroscience",
        "last": "Castillo-Carranza DL",
        "pages": "83",
        "volume": "9"
      },
      "evidence": "Further, transgenic mouse lines expressing human tau aggregates in the entorhinal cortex have shown that tau is mislocalized from axons to cell bodies and dendrites as the mice age (Pooler et al., 2013b)",
      "key": "e833f94bf5ca057a7045b30f201c0bda",
      "line": 223,
      "object": {
        "effect": {
          "fromLoc": {
            "name": "axon",
            "namespace": "GO"
          },
          "toLoc": {
            "name": "cell body",
            "namespace": "GO"
          }
        },
        "modifier": "Translocation"
      },
      "relation": "association",
      "source": 39,
      "target": 54
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        },
        "MeSHAnatomy": {
          "Entorhinal Cortex": true
        },
        "PublicationType": {
          "Review": true
        }
      },
      "citation": {
        "authors": [
          "Castillo-Carranza DL",
          "Guerrero-Muñoz MJ",
          "Shafiei SS"
        ],
        "date": "2017-01-01",
        "db": "PubMed",
        "db_id": "28420982",
        "db_name": "Tau Oligomers: Cytotoxicity, Propagation, and Mitochondrial Damage.",
        "first": "Shafiei SS",
        "journal": "Frontiers in aging neuroscience",
        "last": "Castillo-Carranza DL",
        "pages": "83",
        "volume": "9"
      },
      "evidence": "Further, transgenic mouse lines expressing human tau aggregates in the entorhinal cortex have shown that tau is mislocalized from axons to cell bodies and dendrites as the mice age (Pooler et al., 2013b)",
      "key": "58349b27e943abda6785016dc9cf8dfc",
      "line": 224,
      "object": {
        "effect": {
          "fromLoc": {
            "name": "axon",
            "namespace": "GO"
          },
          "toLoc": {
            "name": "dendrite",
            "namespace": "GO"
          }
        },
        "modifier": "Translocation"
      },
      "relation": "association",
      "source": 39,
      "target": 54
    },
    {
      "annotations": {
        "Confidence": {
          "Low": true
        },
        "MeSHAnatomy": {
          "Entorhinal Cortex": true
        },
        "PublicationType": {
          "Review": true
        }
      },
      "citation": {
        "authors": [
          "Castillo-Carranza DL",
          "Guerrero-Muñoz MJ",
          "Shafiei SS"
        ],
        "date": "2017-01-01",
        "db": "PubMed",
        "db_id": "28420982",
        "db_name": "Tau Oligomers: Cytotoxicity, Propagation, and Mitochondrial Damage.",
        "first": "Shafiei SS",
        "journal": "Frontiers in aging neuroscience",
        "last": "Castillo-Carranza DL",
        "pages": "83",
        "volume": "9"
      },
      "evidence": "A recent study showed that neuronal networks facilitate cell-to-cell transfer of tau via synapses; using a microfluidic device they demonstrated that decreasing synaptic connections weakens tau transfer and the subsequent aggregation on the acceptor cell (Calafate et al., 2015)",
      "key": "99a27694cfb1f530b1aa1a70f339c8bc",
      "line": 232,
      "object": {
        "effect": {
          "fromLoc": {
            "name": "cell",
            "namespace": "GO"
          },
          "toLoc": {
            "name": "cell",
            "namespace": "GO"
          }
        },
        "modifier": "Translocation"
      },
      "relation": "increases",
      "source": 38,
      "target": 54
    },
    {
      "annotations": {
        "Confidence": {
          "Low": true
        },
        "MeSHAnatomy": {
          "Entorhinal Cortex": true
        },
        "PublicationType": {
          "Review": true
        }
      },
      "citation": {
        "authors": [
          "Castillo-Carranza DL",
          "Guerrero-Muñoz MJ",
          "Shafiei SS"
        ],
        "date": "2017-01-01",
        "db": "PubMed",
        "db_id": "28420982",
        "db_name": "Tau Oligomers: Cytotoxicity, Propagation, and Mitochondrial Damage.",
        "first": "Shafiei SS",
        "journal": "Frontiers in aging neuroscience",
        "last": "Castillo-Carranza DL",
        "pages": "83",
        "volume": "9"
      },
      "evidence": "A recent study showed that neuronal networks facilitate cell-to-cell transfer of tau via synapses; using a microfluidic device they demonstrated that decreasing synaptic connections weakens tau transfer and the subsequent aggregation on the acceptor cell (Calafate et al., 2015)",
      "key": "fa3c0902a02b724b533fb0056c1f2e14",
      "line": 233,
      "relation": "association",
      "source": 38,
      "target": 2
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHAnatomy": {
          "Neocortex": true
        },
        "PublicationType": {
          "Review": true
        }
      },
      "citation": {
        "authors": [
          "Castillo-Carranza DL",
          "Guerrero-Muñoz MJ",
          "Shafiei SS"
        ],
        "date": "2017-01-01",
        "db": "PubMed",
        "db_id": "28420982",
        "db_name": "Tau Oligomers: Cytotoxicity, Propagation, and Mitochondrial Damage.",
        "first": "Shafiei SS",
        "journal": "Frontiers in aging neuroscience",
        "last": "Castillo-Carranza DL",
        "pages": "83",
        "volume": "9"
      },
      "evidence": "Recently, more evidence implies that the secretion of tau occurs through unconventional cellular pathways via vesicles known as exosomes (Saman et al., 2012) and ectosomes (Dujardin et al., 2014a)",
      "key": "a2b1564a7f4705c2f9a5ab61fcd29acb",
      "line": 247,
      "object": {
        "effect": {
          "fromLoc": {
            "name": "intracellular",
            "namespace": "bel"
          },
          "toLoc": {
            "name": "extracellular space",
            "namespace": "bel"
          }
        },
        "modifier": "Translocation"
      },
      "relation": "association",
      "source": 19,
      "target": 54
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHAnatomy": {
          "Neocortex": true
        },
        "MeSHDisease": {
          "Alzheimer Disease": true
        },
        "PublicationType": {
          "Review": true
        }
      },
      "citation": {
        "authors": [
          "Castillo-Carranza DL",
          "Guerrero-Muñoz MJ",
          "Shafiei SS"
        ],
        "date": "2017-01-01",
        "db": "PubMed",
        "db_id": "28420982",
        "db_name": "Tau Oligomers: Cytotoxicity, Propagation, and Mitochondrial Damage.",
        "first": "Shafiei SS",
        "journal": "Frontiers in aging neuroscience",
        "last": "Castillo-Carranza DL",
        "pages": "83",
        "volume": "9"
      },
      "evidence": "AD brain samples contain exosomal proteins within amyloid plaques hinting that exosomes play part in disease pathology (Rajendran et al., 2006)",
      "key": "a6318f27a3508fffc3591790f09a8c74",
      "line": 256,
      "relation": "association",
      "source": 19,
      "target": 65
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHAnatomy": {
          "Cerebrospinal Fluid": true
        },
        "MeSHDisease": {
          "Alzheimer Disease": true
        },
        "PublicationType": {
          "Review": true
        }
      },
      "citation": {
        "authors": [
          "Castillo-Carranza DL",
          "Guerrero-Muñoz MJ",
          "Shafiei SS"
        ],
        "date": "2017-01-01",
        "db": "PubMed",
        "db_id": "28420982",
        "db_name": "Tau Oligomers: Cytotoxicity, Propagation, and Mitochondrial Damage.",
        "first": "Shafiei SS",
        "journal": "Frontiers in aging neuroscience",
        "last": "Castillo-Carranza DL",
        "pages": "83",
        "volume": "9"
      },
      "evidence": "In support, tau associated with exosomes and phosphorylated at Thr-181 (AT270+ tau) has been identified in human CSF samples of AD patients",
      "key": "0d026e25cb36d1bf819ba57a7ac1d927",
      "line": 264,
      "relation": "association",
      "source": 19,
      "target": 59
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHAnatomy": {
          "Neocortex": true
        },
        "PublicationType": {
          "Review": true
        }
      },
      "citation": {
        "authors": [
          "Castillo-Carranza DL",
          "Guerrero-Muñoz MJ",
          "Shafiei SS"
        ],
        "date": "2017-01-01",
        "db": "PubMed",
        "db_id": "28420982",
        "db_name": "Tau Oligomers: Cytotoxicity, Propagation, and Mitochondrial Damage.",
        "first": "Shafiei SS",
        "journal": "Frontiers in aging neuroscience",
        "last": "Castillo-Carranza DL",
        "pages": "83",
        "volume": "9"
      },
      "evidence": "Recently, more evidence implies that the secretion of tau occurs through unconventional cellular pathways via vesicles known as exosomes (Saman et al., 2012) and ectosomes (Dujardin et al., 2014a)",
      "key": "6ca15e947202e0a855220debae8bb534",
      "line": 248,
      "object": {
        "effect": {
          "fromLoc": {
            "name": "intracellular",
            "namespace": "bel"
          },
          "toLoc": {
            "name": "extracellular space",
            "namespace": "bel"
          }
        },
        "modifier": "Translocation"
      },
      "relation": "association",
      "source": 12,
      "target": 54
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        },
        "MeSHAnatomy": {
          "Microglia": true
        },
        "MeSHDisease": {
          "Alzheimer Disease": true
        },
        "PublicationType": {
          "Review": true
        }
      },
      "citation": {
        "authors": [
          "Castillo-Carranza DL",
          "Guerrero-Muñoz MJ",
          "Shafiei SS"
        ],
        "date": "2017-01-01",
        "db": "PubMed",
        "db_id": "28420982",
        "db_name": "Tau Oligomers: Cytotoxicity, Propagation, and Mitochondrial Damage.",
        "first": "Shafiei SS",
        "journal": "Frontiers in aging neuroscience",
        "last": "Castillo-Carranza DL",
        "pages": "83",
        "volume": "9"
      },
      "evidence": "Significantly, evidence suggests that tau secretion is partly mediated by ectosomal vesicles and that pathological tau accumulation in cells leads to a deviation toward tau secretion by exosomal vesicles (Dujardin et al., 2014a)",
      "key": "e36f27ffc9f42203134fa58df81815b9",
      "line": 292,
      "object": {
        "effect": {
          "fromLoc": {
            "name": "intracellular",
            "namespace": "bel"
          },
          "toLoc": {
            "name": "extracellular space",
            "namespace": "bel"
          }
        },
        "modifier": "Translocation"
      },
      "relation": "regulates",
      "source": 12,
      "target": 54
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHAnatomy": {
          "Neocortex": true
        },
        "MeSHDisease": {
          "Alzheimer Disease": true
        },
        "PublicationType": {
          "Review": true
        }
      },
      "citation": {
        "authors": [
          "Castillo-Carranza DL",
          "Guerrero-Muñoz MJ",
          "Shafiei SS"
        ],
        "date": "2017-01-01",
        "db": "PubMed",
        "db_id": "28420982",
        "db_name": "Tau Oligomers: Cytotoxicity, Propagation, and Mitochondrial Damage.",
        "first": "Shafiei SS",
        "journal": "Frontiers in aging neuroscience",
        "last": "Castillo-Carranza DL",
        "pages": "83",
        "volume": "9"
      },
      "evidence": "AD brain samples contain exosomal proteins within amyloid plaques hinting that exosomes play part in disease pathology (Rajendran et al., 2006)",
      "key": "67ee968b35aee52f1f52aac0172d50b0",
      "line": 256,
      "relation": "association",
      "source": 65,
      "target": 19
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHAnatomy": {
          "Cerebrospinal Fluid": true
        },
        "MeSHDisease": {
          "Alzheimer Disease": true
        },
        "PublicationType": {
          "Review": true
        }
      },
      "citation": {
        "authors": [
          "Castillo-Carranza DL",
          "Guerrero-Muñoz MJ",
          "Shafiei SS"
        ],
        "date": "2017-01-01",
        "db": "PubMed",
        "db_id": "28420982",
        "db_name": "Tau Oligomers: Cytotoxicity, Propagation, and Mitochondrial Damage.",
        "first": "Shafiei SS",
        "journal": "Frontiers in aging neuroscience",
        "last": "Castillo-Carranza DL",
        "pages": "83",
        "volume": "9"
      },
      "evidence": "In support, tau associated with exosomes and phosphorylated at Thr-181 (AT270+ tau) has been identified in human CSF samples of AD patients",
      "key": "2e2ca093e30e9950a3bc3d4a04207ea6",
      "line": 264,
      "relation": "association",
      "source": 59,
      "target": 19
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        },
        "MeSHAnatomy": {
          "Cerebrospinal Fluid": true
        },
        "MeSHDisease": {
          "Alzheimer Disease": true
        },
        "PublicationType": {
          "Review": true
        }
      },
      "citation": {
        "authors": [
          "Castillo-Carranza DL",
          "Guerrero-Muñoz MJ",
          "Shafiei SS"
        ],
        "date": "2017-01-01",
        "db": "PubMed",
        "db_id": "28420982",
        "db_name": "Tau Oligomers: Cytotoxicity, Propagation, and Mitochondrial Damage.",
        "first": "Shafiei SS",
        "journal": "Frontiers in aging neuroscience",
        "last": "Castillo-Carranza DL",
        "pages": "83",
        "volume": "9"
      },
      "evidence": "More recently, patients affected with FTD and AD, were found to have high levels of total tau and phosphorylated tau (p-T181 and p-S396; Saman et al., 2012)",
      "key": "9f5848621d4432321fe6dc02dc2e9510",
      "line": 273,
      "relation": "positiveCorrelation",
      "source": 59,
      "target": 61
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        },
        "MeSHAnatomy": {
          "Cerebrospinal Fluid": true
        },
        "MeSHDisease": {
          "Alzheimer Disease": true
        },
        "PublicationType": {
          "Review": true
        }
      },
      "citation": {
        "authors": [
          "Castillo-Carranza DL",
          "Guerrero-Muñoz MJ",
          "Shafiei SS"
        ],
        "date": "2017-01-01",
        "db": "PubMed",
        "db_id": "28420982",
        "db_name": "Tau Oligomers: Cytotoxicity, Propagation, and Mitochondrial Damage.",
        "first": "Shafiei SS",
        "journal": "Frontiers in aging neuroscience",
        "last": "Castillo-Carranza DL",
        "pages": "83",
        "volume": "9"
      },
      "evidence": "More recently, patients affected with FTD and AD, were found to have high levels of total tau and phosphorylated tau (p-T181 and p-S396; Saman et al., 2012)",
      "key": "b3c91a2d84646614c42e265135f55a96",
      "line": 276,
      "relation": "positiveCorrelation",
      "source": 59,
      "target": 64
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        },
        "MeSHAnatomy": {
          "Cerebrospinal Fluid": true
        },
        "MeSHDisease": {
          "Alzheimer Disease": true
        },
        "PublicationType": {
          "Review": true
        }
      },
      "citation": {
        "authors": [
          "Castillo-Carranza DL",
          "Guerrero-Muñoz MJ",
          "Shafiei SS"
        ],
        "date": "2017-01-01",
        "db": "PubMed",
        "db_id": "28420982",
        "db_name": "Tau Oligomers: Cytotoxicity, Propagation, and Mitochondrial Damage.",
        "first": "Shafiei SS",
        "journal": "Frontiers in aging neuroscience",
        "last": "Castillo-Carranza DL",
        "pages": "83",
        "volume": "9"
      },
      "evidence": "More recently, patients affected with FTD and AD, were found to have high levels of total tau and phosphorylated tau (p-T181 and p-S396; Saman et al., 2012)",
      "key": "47986d365e54f88fcaf0373d5293b643",
      "line": 272,
      "relation": "positiveCorrelation",
      "source": 58,
      "target": 61
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        },
        "MeSHAnatomy": {
          "Cerebrospinal Fluid": true
        },
        "MeSHDisease": {
          "Alzheimer Disease": true
        },
        "PublicationType": {
          "Review": true
        }
      },
      "citation": {
        "authors": [
          "Castillo-Carranza DL",
          "Guerrero-Muñoz MJ",
          "Shafiei SS"
        ],
        "date": "2017-01-01",
        "db": "PubMed",
        "db_id": "28420982",
        "db_name": "Tau Oligomers: Cytotoxicity, Propagation, and Mitochondrial Damage.",
        "first": "Shafiei SS",
        "journal": "Frontiers in aging neuroscience",
        "last": "Castillo-Carranza DL",
        "pages": "83",
        "volume": "9"
      },
      "evidence": "More recently, patients affected with FTD and AD, were found to have high levels of total tau and phosphorylated tau (p-T181 and p-S396; Saman et al., 2012)",
      "key": "cb280020cebcf3c59bc222d994b85d92",
      "line": 275,
      "relation": "positiveCorrelation",
      "source": 58,
      "target": 64
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        },
        "MeSHAnatomy": {
          "Cerebrospinal Fluid": true
        },
        "MeSHDisease": {
          "Alzheimer Disease": true
        },
        "PublicationType": {
          "Review": true
        }
      },
      "citation": {
        "authors": [
          "Castillo-Carranza DL",
          "Guerrero-Muñoz MJ",
          "Shafiei SS"
        ],
        "date": "2017-01-01",
        "db": "PubMed",
        "db_id": "28420982",
        "db_name": "Tau Oligomers: Cytotoxicity, Propagation, and Mitochondrial Damage.",
        "first": "Shafiei SS",
        "journal": "Frontiers in aging neuroscience",
        "last": "Castillo-Carranza DL",
        "pages": "83",
        "volume": "9"
      },
      "evidence": "More recently, patients affected with FTD and AD, were found to have high levels of total tau and phosphorylated tau (p-T181 and p-S396; Saman et al., 2012)",
      "key": "2b43f3334b435c1de1331a7af443099c",
      "line": 274,
      "relation": "positiveCorrelation",
      "source": 64,
      "target": 54
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        },
        "MeSHAnatomy": {
          "Cerebrospinal Fluid": true
        },
        "MeSHDisease": {
          "Alzheimer Disease": true
        },
        "PublicationType": {
          "Review": true
        }
      },
      "citation": {
        "authors": [
          "Castillo-Carranza DL",
          "Guerrero-Muñoz MJ",
          "Shafiei SS"
        ],
        "date": "2017-01-01",
        "db": "PubMed",
        "db_id": "28420982",
        "db_name": "Tau Oligomers: Cytotoxicity, Propagation, and Mitochondrial Damage.",
        "first": "Shafiei SS",
        "journal": "Frontiers in aging neuroscience",
        "last": "Castillo-Carranza DL",
        "pages": "83",
        "volume": "9"
      },
      "evidence": "More recently, patients affected with FTD and AD, were found to have high levels of total tau and phosphorylated tau (p-T181 and p-S396; Saman et al., 2012)",
      "key": "189452fba11de753891eebeeaab965cf",
      "line": 275,
      "relation": "positiveCorrelation",
      "source": 64,
      "target": 58
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        },
        "MeSHAnatomy": {
          "Cerebrospinal Fluid": true
        },
        "MeSHDisease": {
          "Alzheimer Disease": true
        },
        "PublicationType": {
          "Review": true
        }
      },
      "citation": {
        "authors": [
          "Castillo-Carranza DL",
          "Guerrero-Muñoz MJ",
          "Shafiei SS"
        ],
        "date": "2017-01-01",
        "db": "PubMed",
        "db_id": "28420982",
        "db_name": "Tau Oligomers: Cytotoxicity, Propagation, and Mitochondrial Damage.",
        "first": "Shafiei SS",
        "journal": "Frontiers in aging neuroscience",
        "last": "Castillo-Carranza DL",
        "pages": "83",
        "volume": "9"
      },
      "evidence": "More recently, patients affected with FTD and AD, were found to have high levels of total tau and phosphorylated tau (p-T181 and p-S396; Saman et al., 2012)",
      "key": "8b7852a531691751aee131808d12f832",
      "line": 276,
      "relation": "positiveCorrelation",
      "source": 64,
      "target": 59
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHAnatomy": {
          "Exosomes": true
        },
        "MeSHDisease": {
          "Alzheimer Disease": true
        },
        "PublicationType": {
          "Review": true
        }
      },
      "citation": {
        "authors": [
          "Castillo-Carranza DL",
          "Guerrero-Muñoz MJ",
          "Shafiei SS"
        ],
        "date": "2017-01-01",
        "db": "PubMed",
        "db_id": "28420982",
        "db_name": "Tau Oligomers: Cytotoxicity, Propagation, and Mitochondrial Damage.",
        "first": "Shafiei SS",
        "journal": "Frontiers in aging neuroscience",
        "last": "Castillo-Carranza DL",
        "pages": "83",
        "volume": "9"
      },
      "evidence": "In the latter theory, during the secretion, vesicles and the cell membrane can be fused and uncoated tau protein can be released to the extracellular space (Clavaguera et al., 2009; Iba et al., 2013)",
      "key": "77c99f971f79ec9085f0f574fa20739c",
      "line": 308,
      "object": {
        "effect": {
          "fromLoc": {
            "name": "intracellular",
            "namespace": "bel"
          },
          "toLoc": {
            "name": "extracellular space",
            "namespace": "bel"
          }
        },
        "modifier": "Translocation"
      },
      "relation": "increases",
      "source": 42,
      "target": 54
    },
    {
      "key": "11b637dc69499078c58fad3e0fce563c",
      "relation": "partOf",
      "source": 14,
      "target": 42
    },
    {
      "key": "182eea520fee60a98279a9b98692254d",
      "relation": "partOf",
      "source": 15,
      "target": 42
    },
    {
      "annotations": {
        "CellStructure": {
          "Extracellular Space": true
        },
        "Confidence": {
          "High": true
        },
        "MeSHAnatomy": {
          "Exosomes": true
        },
        "MeSHDisease": {
          "Alzheimer Disease": true
        },
        "PublicationType": {
          "Review": true
        }
      },
      "citation": {
        "authors": [
          "Castillo-Carranza DL",
          "Guerrero-Muñoz MJ",
          "Shafiei SS"
        ],
        "date": "2017-01-01",
        "db": "PubMed",
        "db_id": "28420982",
        "db_name": "Tau Oligomers: Cytotoxicity, Propagation, and Mitochondrial Damage.",
        "first": "Shafiei SS",
        "journal": "Frontiers in aging neuroscience",
        "last": "Castillo-Carranza DL",
        "pages": "83",
        "volume": "9"
      },
      "evidence": "In other words, it is sensible to theorize that tauopathies progress via interaction of extracellular tau with M1 and M3 receptors on neurons leading to cytotoxic effects (Gómez-Ramos et al., 2009)",
      "key": "0dd7df30e79cd8bf3d58647e666627eb",
      "line": 323,
      "relation": "increases",
      "source": 45,
      "target": 68
    },
    {
      "key": "cf7cd2159fe998eab63744f8a85732ea",
      "relation": "partOf",
      "source": 50,
      "target": 45
    },
    {
      "annotations": {
        "CellStructure": {
          "Extracellular Space": true
        },
        "Confidence": {
          "High": true
        },
        "MeSHAnatomy": {
          "Exosomes": true
        },
        "MeSHDisease": {
          "Alzheimer Disease": true
        },
        "PublicationType": {
          "Review": true
        }
      },
      "citation": {
        "authors": [
          "Castillo-Carranza DL",
          "Guerrero-Muñoz MJ",
          "Shafiei SS"
        ],
        "date": "2017-01-01",
        "db": "PubMed",
        "db_id": "28420982",
        "db_name": "Tau Oligomers: Cytotoxicity, Propagation, and Mitochondrial Damage.",
        "first": "Shafiei SS",
        "journal": "Frontiers in aging neuroscience",
        "last": "Castillo-Carranza DL",
        "pages": "83",
        "volume": "9"
      },
      "evidence": "In other words, it is sensible to theorize that tauopathies progress via interaction of extracellular tau with M1 and M3 receptors on neurons leading to cytotoxic effects (Gómez-Ramos et al., 2009)",
      "key": "733c39ae4ae498a0ca0c4c35bba6bf27",
      "line": 324,
      "relation": "increases",
      "source": 46,
      "target": 68
    },
    {
      "key": "ae93780fd51c1231b962f322877969c3",
      "relation": "partOf",
      "source": 51,
      "target": 46
    },
    {
      "annotations": {
        "CellStructure": {
          "Extracellular Space": true
        },
        "Confidence": {
          "High": true
        },
        "MeSHAnatomy": {
          "Exosomes": true
        },
        "MeSHDisease": {
          "Alzheimer Disease": true
        },
        "PublicationType": {
          "Review": true
        }
      },
      "citation": {
        "authors": [
          "Castillo-Carranza DL",
          "Guerrero-Muñoz MJ",
          "Shafiei SS"
        ],
        "date": "2017-01-01",
        "db": "PubMed",
        "db_id": "28420982",
        "db_name": "Tau Oligomers: Cytotoxicity, Propagation, and Mitochondrial Damage.",
        "first": "Shafiei SS",
        "journal": "Frontiers in aging neuroscience",
        "last": "Castillo-Carranza DL",
        "pages": "83",
        "volume": "9"
      },
      "evidence": "Evidence shows that tau aggregates colocalize with dextran and HeLa cells, hinting that internalized aggregates are transported in endosomal vesicles and passed through the endosomal pathway to lysosomes (Wu et al., 2013)",
      "key": "2646b9640005f123ff21e2366d0beb3b",
      "line": 332,
      "relation": "association",
      "source": 1,
      "target": 2
    },
    {
      "annotations": {
        "CellStructure": {
          "Extracellular Space": true
        },
        "Confidence": {
          "High": true
        },
        "MeSHAnatomy": {
          "Exosomes": true
        },
        "MeSHDisease": {
          "Alzheimer Disease": true
        },
        "PublicationType": {
          "Review": true
        }
      },
      "citation": {
        "authors": [
          "Castillo-Carranza DL",
          "Guerrero-Muñoz MJ",
          "Shafiei SS"
        ],
        "date": "2017-01-01",
        "db": "PubMed",
        "db_id": "28420982",
        "db_name": "Tau Oligomers: Cytotoxicity, Propagation, and Mitochondrial Damage.",
        "first": "Shafiei SS",
        "journal": "Frontiers in aging neuroscience",
        "last": "Castillo-Carranza DL",
        "pages": "83",
        "volume": "9"
      },
      "evidence": "Evidence shows that tau aggregates colocalize with dextran and HeLa cells, hinting that internalized aggregates are transported in endosomal vesicles and passed through the endosomal pathway to lysosomes (Wu et al., 2013)",
      "key": "b012230dae88383b8551e585c6c2834d",
      "line": 333,
      "object": {
        "effect": {
          "fromLoc": {
            "name": "endosome",
            "namespace": "GO"
          },
          "toLoc": {
            "name": "lysosome",
            "namespace": "GO"
          }
        },
        "modifier": "Translocation"
      },
      "relation": "increases",
      "source": 33,
      "target": 2
    },
    {
      "annotations": {
        "CellStructure": {
          "Extracellular Space": true
        },
        "Confidence": {
          "High": true
        },
        "MeSHAnatomy": {
          "Exosomes": true
        },
        "MeSHDisease": {
          "Alzheimer Disease": true
        },
        "PublicationType": {
          "Review": true
        }
      },
      "citation": {
        "authors": [
          "Castillo-Carranza DL",
          "Guerrero-Muñoz MJ",
          "Shafiei SS"
        ],
        "date": "2017-01-01",
        "db": "PubMed",
        "db_id": "28420982",
        "db_name": "Tau Oligomers: Cytotoxicity, Propagation, and Mitochondrial Damage.",
        "first": "Shafiei SS",
        "journal": "Frontiers in aging neuroscience",
        "last": "Castillo-Carranza DL",
        "pages": "83",
        "volume": "9"
      },
      "evidence": "Previous studies suggest that uptake of aggregated tau from the extracellular space depends on interaction with heparan sulfate proteoglycans (HSPGs; Holmes and Diamond, 2014)",
      "key": "a9182d284b2e09f9c28124e589be3bd6",
      "line": 339,
      "object": {
        "effect": {
          "fromLoc": {
            "name": "extracellular space",
            "namespace": "GO"
          },
          "toLoc": {
            "name": "intracellular part",
            "namespace": "GO"
          }
        },
        "modifier": "Translocation"
      },
      "relation": "increases",
      "source": 41,
      "target": 2
    },
    {
      "annotations": {
        "CellStructure": {
          "Extracellular Space": true
        },
        "Confidence": {
          "High": true
        },
        "MeSHAnatomy": {
          "Neurons": true
        },
        "MeSHDisease": {
          "Alzheimer Disease": true
        },
        "PublicationType": {
          "Review": true
        }
      },
      "citation": {
        "authors": [
          "Castillo-Carranza DL",
          "Guerrero-Muñoz MJ",
          "Shafiei SS"
        ],
        "date": "2017-01-01",
        "db": "PubMed",
        "db_id": "28420982",
        "db_name": "Tau Oligomers: Cytotoxicity, Propagation, and Mitochondrial Damage.",
        "first": "Shafiei SS",
        "journal": "Frontiers in aging neuroscience",
        "last": "Castillo-Carranza DL",
        "pages": "83",
        "volume": "9"
      },
      "evidence": "Basically, pathogenic tau aggregates use HSPGs to bind the cell surface of a neuron. This actively stimulates macropinocytosis, leading to propagation of aggregates between cells in culture and aggregate uptake in vivo (Holmes et al., 2013)",
      "key": "05070a5f7723bcabedc5f80a38f7db6c",
      "line": 379,
      "relation": "increases",
      "source": 41,
      "target": 2
    },
    {
      "annotations": {
        "CellStructure": {
          "Extracellular Space": true
        },
        "Confidence": {
          "High": true
        },
        "MeSHAnatomy": {
          "Neurons": true
        },
        "MeSHDisease": {
          "Alzheimer Disease": true
        },
        "PublicationType": {
          "Review": true
        }
      },
      "citation": {
        "authors": [
          "Castillo-Carranza DL",
          "Guerrero-Muñoz MJ",
          "Shafiei SS"
        ],
        "date": "2017-01-01",
        "db": "PubMed",
        "db_id": "28420982",
        "db_name": "Tau Oligomers: Cytotoxicity, Propagation, and Mitochondrial Damage.",
        "first": "Shafiei SS",
        "journal": "Frontiers in aging neuroscience",
        "last": "Castillo-Carranza DL",
        "pages": "83",
        "volume": "9"
      },
      "evidence": "Basically, pathogenic tau aggregates use HSPGs to bind the cell surface of a neuron. This actively stimulates macropinocytosis, leading to propagation of aggregates between cells in culture and aggregate uptake in vivo (Holmes et al., 2013)",
      "key": "f5cbd90e706fceeb6923c57675faeb36",
      "line": 377,
      "relation": "increases",
      "source": 41,
      "target": 40
    },
    {
      "annotations": {
        "CellStructure": {
          "Extracellular Space": true
        },
        "Confidence": {
          "High": true
        },
        "MeSHAnatomy": {
          "Neurons": true
        },
        "MeSHDisease": {
          "Alzheimer Disease": true
        },
        "PublicationType": {
          "Review": true
        }
      },
      "citation": {
        "authors": [
          "Castillo-Carranza DL",
          "Guerrero-Muñoz MJ",
          "Shafiei SS"
        ],
        "date": "2017-01-01",
        "db": "PubMed",
        "db_id": "28420982",
        "db_name": "Tau Oligomers: Cytotoxicity, Propagation, and Mitochondrial Damage.",
        "first": "Shafiei SS",
        "journal": "Frontiers in aging neuroscience",
        "last": "Castillo-Carranza DL",
        "pages": "83",
        "volume": "9"
      },
      "evidence": "Basically, pathogenic tau aggregates use HSPGs to bind the cell surface of a neuron. This actively stimulates macropinocytosis, leading to propagation of aggregates between cells in culture and aggregate uptake in vivo (Holmes et al., 2013)",
      "key": "a11b4ef5c8cc69207e19d46dec9060d3",
      "line": 378,
      "relation": "increases",
      "source": 41,
      "target": 34
    },
    {
      "key": "bde1fa89557266d17467e91e7e2a31d3",
      "relation": "partOf",
      "source": 17,
      "target": 41
    },
    {
      "annotations": {
        "CellStructure": {
          "Extracellular Space": true
        },
        "Confidence": {
          "High": true
        },
        "MeSHAnatomy": {
          "Exosomes": true
        },
        "MeSHDisease": {
          "Alzheimer Disease": true
        },
        "PublicationType": {
          "Review": true
        }
      },
      "citation": {
        "authors": [
          "Castillo-Carranza DL",
          "Guerrero-Muñoz MJ",
          "Shafiei SS"
        ],
        "date": "2017-01-01",
        "db": "PubMed",
        "db_id": "28420982",
        "db_name": "Tau Oligomers: Cytotoxicity, Propagation, and Mitochondrial Damage.",
        "first": "Shafiei SS",
        "journal": "Frontiers in aging neuroscience",
        "last": "Castillo-Carranza DL",
        "pages": "83",
        "volume": "9"
      },
      "evidence": "HSPGs are ubiquitously expressed in many cell types including neurons, and have been previously associated with dense core plaques, cerebrovascular amyloid, and NFT formation (van Horssen et al., 2001)",
      "key": "ebea4eafea25d3616bc2c178165652f2",
      "line": 346,
      "relation": "association",
      "source": 17,
      "target": 28
    },
    {
      "annotations": {
        "CellStructure": {
          "Extracellular Space": true
        },
        "Confidence": {
          "High": true
        },
        "MeSHAnatomy": {
          "Exosomes": true
        },
        "MeSHDisease": {
          "Alzheimer Disease": true
        },
        "PublicationType": {
          "Review": true
        }
      },
      "citation": {
        "authors": [
          "Castillo-Carranza DL",
          "Guerrero-Muñoz MJ",
          "Shafiei SS"
        ],
        "date": "2017-01-01",
        "db": "PubMed",
        "db_id": "28420982",
        "db_name": "Tau Oligomers: Cytotoxicity, Propagation, and Mitochondrial Damage.",
        "first": "Shafiei SS",
        "journal": "Frontiers in aging neuroscience",
        "last": "Castillo-Carranza DL",
        "pages": "83",
        "volume": "9"
      },
      "evidence": "HSPGs are ubiquitously expressed in many cell types including neurons, and have been previously associated with dense core plaques, cerebrovascular amyloid, and NFT formation (van Horssen et al., 2001)",
      "key": "4618c53e002cdcf43add2df431ba1a03",
      "line": 347,
      "relation": "association",
      "source": 17,
      "target": 7
    },
    {
      "annotations": {
        "CellStructure": {
          "Extracellular Space": true
        },
        "Confidence": {
          "High": true
        },
        "MeSHAnatomy": {
          "Exosomes": true
        },
        "MeSHDisease": {
          "Alzheimer Disease": true
        },
        "PublicationType": {
          "Review": true
        }
      },
      "citation": {
        "authors": [
          "Castillo-Carranza DL",
          "Guerrero-Muñoz MJ",
          "Shafiei SS"
        ],
        "date": "2017-01-01",
        "db": "PubMed",
        "db_id": "28420982",
        "db_name": "Tau Oligomers: Cytotoxicity, Propagation, and Mitochondrial Damage.",
        "first": "Shafiei SS",
        "journal": "Frontiers in aging neuroscience",
        "last": "Castillo-Carranza DL",
        "pages": "83",
        "volume": "9"
      },
      "evidence": "HSPGs are ubiquitously expressed in many cell types including neurons, and have been previously associated with dense core plaques, cerebrovascular amyloid, and NFT formation (van Horssen et al., 2001)",
      "key": "4b194e1ed8acb2ed9dddb5eac7f4c8b3",
      "line": 348,
      "relation": "association",
      "source": 17,
      "target": 63
    },
    {
      "annotations": {
        "CellStructure": {
          "Extracellular Space": true
        },
        "Confidence": {
          "High": true
        },
        "MeSHAnatomy": {
          "Exosomes": true
        },
        "MeSHDisease": {
          "Alzheimer Disease": true
        },
        "PublicationType": {
          "Review": true
        }
      },
      "citation": {
        "authors": [
          "Castillo-Carranza DL",
          "Guerrero-Muñoz MJ",
          "Shafiei SS"
        ],
        "date": "2017-01-01",
        "db": "PubMed",
        "db_id": "28420982",
        "db_name": "Tau Oligomers: Cytotoxicity, Propagation, and Mitochondrial Damage.",
        "first": "Shafiei SS",
        "journal": "Frontiers in aging neuroscience",
        "last": "Castillo-Carranza DL",
        "pages": "83",
        "volume": "9"
      },
      "evidence": "Consistently, HSPGs have been implicated in amyloid as well as tau fibril formation in vitro, presumably facilitated by anionic moieties",
      "key": "d7d655aa45186ba2508a44a08dd42c17",
      "line": 354,
      "relation": "increases",
      "source": 17,
      "target": 4
    },
    {
      "annotations": {
        "CellStructure": {
          "Extracellular Space": true
        },
        "Confidence": {
          "High": true
        },
        "MeSHAnatomy": {
          "Exosomes": true
        },
        "MeSHDisease": {
          "Alzheimer Disease": true
        },
        "PublicationType": {
          "Review": true
        }
      },
      "citation": {
        "authors": [
          "Castillo-Carranza DL",
          "Guerrero-Muñoz MJ",
          "Shafiei SS"
        ],
        "date": "2017-01-01",
        "db": "PubMed",
        "db_id": "28420982",
        "db_name": "Tau Oligomers: Cytotoxicity, Propagation, and Mitochondrial Damage.",
        "first": "Shafiei SS",
        "journal": "Frontiers in aging neuroscience",
        "last": "Castillo-Carranza DL",
        "pages": "83",
        "volume": "9"
      },
      "evidence": "Consistently, HSPGs have been implicated in amyloid as well as tau fibril formation in vitro, presumably facilitated by anionic moieties",
      "key": "2e04db76ff304fbd6064670fd16b4cd2",
      "line": 355,
      "relation": "increases",
      "source": 17,
      "target": 6
    },
    {
      "annotations": {
        "CellStructure": {
          "Extracellular Space": true
        },
        "Confidence": {
          "High": true
        },
        "MeSHAnatomy": {
          "Exosomes": true
        },
        "MeSHDisease": {
          "Alzheimer Disease": true
        },
        "PublicationType": {
          "Review": true
        }
      },
      "citation": {
        "authors": [
          "Castillo-Carranza DL",
          "Guerrero-Muñoz MJ",
          "Shafiei SS"
        ],
        "date": "2017-01-01",
        "db": "PubMed",
        "db_id": "28420982",
        "db_name": "Tau Oligomers: Cytotoxicity, Propagation, and Mitochondrial Damage.",
        "first": "Shafiei SS",
        "journal": "Frontiers in aging neuroscience",
        "last": "Castillo-Carranza DL",
        "pages": "83",
        "volume": "9"
      },
      "evidence": "However, regardless of the multiple “sizes” of tau aggregates that interact with the cell surface via HSPGs, it is likely that an assembly of at least three tau molecules is required to initiate endocytosis via HSPGs (Mirbaha et al., 2015)",
      "key": "40d81172f8523a978bc56df30b148e28",
      "line": 363,
      "relation": "increases",
      "source": 17,
      "target": 40
    },
    {
      "annotations": {
        "CellStructure": {
          "Extracellular Space": true
        },
        "Confidence": {
          "High": true
        },
        "MeSHAnatomy": {
          "Exosomes": true
        },
        "MeSHDisease": {
          "Alzheimer Disease": true
        },
        "PublicationType": {
          "Review": true
        }
      },
      "citation": {
        "authors": [
          "Castillo-Carranza DL",
          "Guerrero-Muñoz MJ",
          "Shafiei SS"
        ],
        "date": "2017-01-01",
        "db": "PubMed",
        "db_id": "28420982",
        "db_name": "Tau Oligomers: Cytotoxicity, Propagation, and Mitochondrial Damage.",
        "first": "Shafiei SS",
        "journal": "Frontiers in aging neuroscience",
        "last": "Castillo-Carranza DL",
        "pages": "83",
        "volume": "9"
      },
      "evidence": "In other words, the HSPGs serve as a receptor for the cellular uptake of tau, a critical step similar to prion-like propagation",
      "key": "8b1f679dca60ee99d54aae9b18149823",
      "line": 369,
      "object": {
        "effect": {
          "fromLoc": {
            "name": "extracellular space",
            "namespace": "GO"
          },
          "toLoc": {
            "name": "intracellular part",
            "namespace": "GO"
          }
        },
        "modifier": "Translocation"
      },
      "relation": "increases",
      "source": 17,
      "target": 54
    },
    {
      "annotations": {
        "CellStructure": {
          "Extracellular Space": true
        },
        "Confidence": {
          "High": true
        },
        "MeSHAnatomy": {
          "Exosomes": true
        },
        "MeSHDisease": {
          "Alzheimer Disease": true
        },
        "PublicationType": {
          "Review": true
        }
      },
      "citation": {
        "authors": [
          "Castillo-Carranza DL",
          "Guerrero-Muñoz MJ",
          "Shafiei SS"
        ],
        "date": "2017-01-01",
        "db": "PubMed",
        "db_id": "28420982",
        "db_name": "Tau Oligomers: Cytotoxicity, Propagation, and Mitochondrial Damage.",
        "first": "Shafiei SS",
        "journal": "Frontiers in aging neuroscience",
        "last": "Castillo-Carranza DL",
        "pages": "83",
        "volume": "9"
      },
      "evidence": "HSPGs are ubiquitously expressed in many cell types including neurons, and have been previously associated with dense core plaques, cerebrovascular amyloid, and NFT formation (van Horssen et al., 2001)",
      "key": "b97cc69bae6849bf4f4930fb4024ea0e",
      "line": 346,
      "relation": "association",
      "source": 28,
      "target": 17
    },
    {
      "annotations": {
        "CellStructure": {
          "Extracellular Space": true
        },
        "Confidence": {
          "High": true
        },
        "MeSHAnatomy": {
          "Exosomes": true
        },
        "MeSHDisease": {
          "Alzheimer Disease": true
        },
        "PublicationType": {
          "Review": true
        }
      },
      "citation": {
        "authors": [
          "Castillo-Carranza DL",
          "Guerrero-Muñoz MJ",
          "Shafiei SS"
        ],
        "date": "2017-01-01",
        "db": "PubMed",
        "db_id": "28420982",
        "db_name": "Tau Oligomers: Cytotoxicity, Propagation, and Mitochondrial Damage.",
        "first": "Shafiei SS",
        "journal": "Frontiers in aging neuroscience",
        "last": "Castillo-Carranza DL",
        "pages": "83",
        "volume": "9"
      },
      "evidence": "HSPGs are ubiquitously expressed in many cell types including neurons, and have been previously associated with dense core plaques, cerebrovascular amyloid, and NFT formation (van Horssen et al., 2001)",
      "key": "44a92fdfefbe2641e59ccfc16e871f24",
      "line": 347,
      "relation": "association",
      "source": 7,
      "target": 17
    },
    {
      "annotations": {
        "CellStructure": {
          "Extracellular Space": true
        },
        "Confidence": {
          "High": true
        },
        "MeSHAnatomy": {
          "Exosomes": true
        },
        "MeSHDisease": {
          "Alzheimer Disease": true
        },
        "PublicationType": {
          "Review": true
        }
      },
      "citation": {
        "authors": [
          "Castillo-Carranza DL",
          "Guerrero-Muñoz MJ",
          "Shafiei SS"
        ],
        "date": "2017-01-01",
        "db": "PubMed",
        "db_id": "28420982",
        "db_name": "Tau Oligomers: Cytotoxicity, Propagation, and Mitochondrial Damage.",
        "first": "Shafiei SS",
        "journal": "Frontiers in aging neuroscience",
        "last": "Castillo-Carranza DL",
        "pages": "83",
        "volume": "9"
      },
      "evidence": "HSPGs are ubiquitously expressed in many cell types including neurons, and have been previously associated with dense core plaques, cerebrovascular amyloid, and NFT formation (van Horssen et al., 2001)",
      "key": "96b6f696afb5eb125612086a036195ed",
      "line": 348,
      "relation": "association",
      "source": 63,
      "target": 17
    },
    {
      "key": "1a36a0a2e6981a4e57c7372485e2e326",
      "relation": "partOf",
      "source": 9,
      "target": 40
    },
    {
      "annotations": {
        "CellStructure": {
          "Extracellular Space": true
        },
        "Confidence": {
          "High": true
        },
        "MeSHAnatomy": {
          "Neurons": true
        },
        "MeSHDisease": {
          "Alzheimer Disease": true
        },
        "PublicationType": {
          "Review": true
        }
      },
      "citation": {
        "authors": [
          "Castillo-Carranza DL",
          "Guerrero-Muñoz MJ",
          "Shafiei SS"
        ],
        "date": "2017-01-01",
        "db": "PubMed",
        "db_id": "28420982",
        "db_name": "Tau Oligomers: Cytotoxicity, Propagation, and Mitochondrial Damage.",
        "first": "Shafiei SS",
        "journal": "Frontiers in aging neuroscience",
        "last": "Castillo-Carranza DL",
        "pages": "83",
        "volume": "9"
      },
      "evidence": "Hence, tau APFs may play a significant role in tauopathies by linking pore formation to cell death",
      "key": "f444a24d4fd452e1de03924348670211",
      "line": 391,
      "relation": "association",
      "source": 3,
      "target": 68
    },
    {
      "annotations": {
        "CellStructure": {
          "Extracellular Space": true
        },
        "Confidence": {
          "Medium": true
        },
        "MeSHAnatomy": {
          "Neurons": true
        },
        "MeSHDisease": {
          "Alzheimer Disease": true
        },
        "PublicationType": {
          "Review": true
        }
      },
      "citation": {
        "authors": [
          "Castillo-Carranza DL",
          "Guerrero-Muñoz MJ",
          "Shafiei SS"
        ],
        "date": "2017-01-01",
        "db": "PubMed",
        "db_id": "28420982",
        "db_name": "Tau Oligomers: Cytotoxicity, Propagation, and Mitochondrial Damage.",
        "first": "Shafiei SS",
        "journal": "Frontiers in aging neuroscience",
        "last": "Castillo-Carranza DL",
        "pages": "83",
        "volume": "9"
      },
      "evidence": "In aging, a protein involved in mitochondrial fission, dynamin-related protein 1 (DRP1), can bind tau abnormally, inducing neurodegeneration via mitochondrial dysfunction (Figure 2; DuBoff et al., 2012)",
      "key": "601e545ef609cb380e7c2fcbcc09a8b2",
      "line": 403,
      "relation": "increases",
      "source": 47,
      "target": 36
    },
    {
      "key": "8854c8825b7da03da287700062ab738d",
      "relation": "partOf",
      "source": 53,
      "target": 47
    },
    {
      "annotations": {
        "CellStructure": {
          "Extracellular Space": true
        },
        "Confidence": {
          "Low": true
        },
        "MeSHAnatomy": {
          "Neurons": true
        },
        "MeSHDisease": {
          "Alzheimer Disease": true
        },
        "PublicationType": {
          "Review": true
        }
      },
      "citation": {
        "authors": [
          "Castillo-Carranza DL",
          "Guerrero-Muñoz MJ",
          "Shafiei SS"
        ],
        "date": "2017-01-01",
        "db": "PubMed",
        "db_id": "28420982",
        "db_name": "Tau Oligomers: Cytotoxicity, Propagation, and Mitochondrial Damage.",
        "first": "Shafiei SS",
        "journal": "Frontiers in aging neuroscience",
        "last": "Castillo-Carranza DL",
        "pages": "83",
        "volume": "9"
      },
      "evidence": "Another study showed that expression of tau (truncated at Asp-421 to mimic caspase cleavage) caused mitochondrial dysfunction (Quintanilla et al., 2009)",
      "key": "b0f6b6bcb6a88d0379b5047e8f61f8ed",
      "line": 412,
      "relation": "decreases",
      "source": 55,
      "target": 27
    },
    {
      "annotations": {
        "CellStructure": {
          "Extracellular Space": true
        },
        "Confidence": {
          "Low": true
        },
        "MeSHAnatomy": {
          "Neurons": true
        },
        "MeSHDisease": {
          "Alzheimer Disease": true
        },
        "PublicationType": {
          "Review": true
        }
      },
      "citation": {
        "authors": [
          "Castillo-Carranza DL",
          "Guerrero-Muñoz MJ",
          "Shafiei SS"
        ],
        "date": "2017-01-01",
        "db": "PubMed",
        "db_id": "28420982",
        "db_name": "Tau Oligomers: Cytotoxicity, Propagation, and Mitochondrial Damage.",
        "first": "Shafiei SS",
        "journal": "Frontiers in aging neuroscience",
        "last": "Castillo-Carranza DL",
        "pages": "83",
        "volume": "9"
      },
      "evidence": "Another study showed that expression of tau (truncated at Asp-421 to mimic caspase cleavage) caused mitochondrial dysfunction (Quintanilla et al., 2009)",
      "key": "6836ce1b2bbc218ab69ebcbbdedda8cd",
      "line": 413,
      "relation": "decreases",
      "source": 56,
      "target": 27
    },
    {
      "annotations": {
        "CellStructure": {
          "Extracellular Space": true
        },
        "Confidence": {
          "High": true
        },
        "MeSHAnatomy": {
          "Neurons": true
        },
        "MeSHDisease": {
          "Alzheimer Disease": true
        },
        "PublicationType": {
          "Review": true
        }
      },
      "citation": {
        "authors": [
          "Castillo-Carranza DL",
          "Guerrero-Muñoz MJ",
          "Shafiei SS"
        ],
        "date": "2017-01-01",
        "db": "PubMed",
        "db_id": "28420982",
        "db_name": "Tau Oligomers: Cytotoxicity, Propagation, and Mitochondrial Damage.",
        "first": "Shafiei SS",
        "journal": "Frontiers in aging neuroscience",
        "last": "Castillo-Carranza DL",
        "pages": "83",
        "volume": "9"
      },
      "evidence": "Recently, data has shown that injected tau oligomers colocalize with the mitochondrial marker porin, suggesting a pathological relationship",
      "key": "bda106b876850d0298e19c76fa876784",
      "line": 418,
      "relation": "association",
      "source": 60,
      "target": 5
    },
    {
      "key": "c4f50c1db2d6521eac6c121494a9b0b8",
      "relation": "partOf",
      "source": 52,
      "target": 44
    },
    {
      "annotations": {
        "CellStructure": {
          "Mitochondrial Membranes": true
        },
        "Confidence": {
          "Medium": true
        },
        "MeSHAnatomy": {
          "Neurons": true
        },
        "MeSHDisease": {
          "Alzheimer Disease": true
        },
        "PublicationType": {
          "Review": true
        }
      },
      "citation": {
        "authors": [
          "Castillo-Carranza DL",
          "Guerrero-Muñoz MJ",
          "Shafiei SS"
        ],
        "date": "2017-01-01",
        "db": "PubMed",
        "db_id": "28420982",
        "db_name": "Tau Oligomers: Cytotoxicity, Propagation, and Mitochondrial Damage.",
        "first": "Shafiei SS",
        "journal": "Frontiers in aging neuroscience",
        "last": "Castillo-Carranza DL",
        "pages": "83",
        "volume": "9"
      },
      "evidence": "Suggestively, as tau oligomers concentrate at the mitochondrial membrane, cytochrome C is released, leading to caspase-9 activation via a complex with apoptotic-peptidase activating- factor-1 (Apaf-1; Li et al., 1997)",
      "key": "6315b77ed42ee18978bc62f82ca86a45",
      "line": 453,
      "object": {
        "modifier": "Activity"
      },
      "relation": "increases",
      "source": 44,
      "target": 49
    },
    {
      "key": "ad1868e24adb227e368301ee6c15e956",
      "relation": "partOf",
      "source": 48,
      "target": 44
    }
  ],
  "multigraph": true,
  "nodes": [
    {
      "bel": "a(CHEBI:\"calcium(2+)\")",
      "concept": {
        "name": "calcium(2+)",
        "namespace": "CHEBI"
      },
      "function": "Abundance",
      "id": "94df77a2db8d9014b42535235da90e5d"
    },
    {
      "bel": "a(CHEBI:dextran)",
      "concept": {
        "name": "dextran",
        "namespace": "CHEBI"
      },
      "function": "Abundance",
      "id": "75768dbcb3bfefff1f2e988788b8bb59"
    },
    {
      "bel": "a(CONSO:\"Tau aggregates\")",
      "concept": {
        "name": "Tau aggregates",
        "namespace": "CONSO"
      },
      "function": "Abundance",
      "id": "8e1da50e6008ffdd1b37825776666311"
    },
    {
      "bel": "a(CONSO:\"Tau annular protofibrils\")",
      "concept": {
        "name": "Tau annular protofibrils",
        "namespace": "CONSO"
      },
      "function": "Abundance",
      "id": "a23477e7346d818ba7a2385118a499f5"
    },
    {
      "bel": "a(CONSO:\"Tau fibrils\")",
      "concept": {
        "name": "Tau fibrils",
        "namespace": "CONSO"
      },
      "function": "Abundance",
      "id": "1b18e2b527ac0db7353b67d4534c033e"
    },
    {
      "bel": "a(CONSO:\"Tau oligomers\")",
      "concept": {
        "name": "Tau oligomers",
        "namespace": "CONSO"
      },
      "function": "Abundance",
      "id": "d45e1cc48bdfb58b4ead6900919dbbe3"
    },
    {
      "bel": "a(CONSO:\"amyloid-beta fibrils\")",
      "concept": {
        "name": "amyloid-beta fibrils",
        "namespace": "CONSO"
      },
      "function": "Abundance",
      "id": "b0d56b42446bae9f5fb7dbdf434d93af"
    },
    {
      "bel": "a(CONSO:\"dense core plaques\")",
      "concept": {
        "name": "dense core plaques",
        "namespace": "CONSO"
      },
      "function": "Abundance",
      "id": "fca914c0f34bcf130cc1de8f63d450f2"
    },
    {
      "bel": "a(CONSO:\"granular tau oligomers\")",
      "concept": {
        "name": "granular tau oligomers",
        "namespace": "CONSO"
      },
      "function": "Abundance",
      "id": "060ff404f01f7101eb9fb33301e32e9b"
    },
    {
      "bel": "a(GO:\"cell surface\")",
      "concept": {
        "name": "cell surface",
        "namespace": "GO"
      },
      "function": "Abundance",
      "id": "e5fa02451051e3ddcc8a6c3289445bc9"
    },
    {
      "bel": "a(GO:\"neurofibrillary tangle\")",
      "concept": {
        "name": "neurofibrillary tangle",
        "namespace": "GO"
      },
      "function": "Abundance",
      "id": "274b01539a0746fbee06884b2af6c533"
    },
    {
      "bel": "a(GO:microtubule)",
      "concept": {
        "name": "microtubule",
        "namespace": "GO"
      },
      "function": "Abundance",
      "id": "0fe6be9622e5650da7dca7cdced2f9db"
    },
    {
      "bel": "a(GO:microvesicle)",
      "concept": {
        "name": "microvesicle",
        "namespace": "GO"
      },
      "function": "Abundance",
      "id": "2fc26e77737eeb3c63c4b02813c0a9ee"
    },
    {
      "bel": "a(GO:synapse)",
      "concept": {
        "name": "synapse",
        "namespace": "GO"
      },
      "function": "Abundance",
      "id": "69c474d54609b66889d95380bd3d9a19"
    },
    {
      "bel": "a(GO:vesicle)",
      "concept": {
        "name": "vesicle",
        "namespace": "GO"
      },
      "function": "Abundance",
      "id": "289ddc95e92756879e07751d19bf7025"
    },
    {
      "bel": "a(MESH:\"Cell Membrane\")",
      "concept": {
        "name": "Cell Membrane",
        "namespace": "MESH"
      },
      "function": "Abundance",
      "id": "5f1f124138addc7af92d1beca50bdbd4"
    },
    {
      "bel": "a(MESH:\"Electron Transport Complex I\")",
      "concept": {
        "name": "Electron Transport Complex I",
        "namespace": "MESH"
      },
      "function": "Abundance",
      "id": "41698d9f2a36ca8abae1ccbb1d0295f1"
    },
    {
      "bel": "a(MESH:\"Heparan Sulfate Proteoglycans\")",
      "concept": {
        "name": "Heparan Sulfate Proteoglycans",
        "namespace": "MESH"
      },
      "function": "Abundance",
      "id": "ca0c2459dc50ea6388244eec62e9d530"
    },
    {
      "bel": "a(MESH:\"Receptors, N-Methyl-D-Aspartate\")",
      "concept": {
        "name": "Receptors, N-Methyl-D-Aspartate",
        "namespace": "MESH"
      },
      "function": "Abundance",
      "id": "9243c01ac01a47ab2b889a759940325e"
    },
    {
      "bel": "a(MESH:Exosomes)",
      "concept": {
        "name": "Exosomes",
        "namespace": "MESH"
      },
      "function": "Abundance",
      "id": "67c563da175755c23bbdfedd4f1b24af"
    },
    {
      "bel": "bp(GO:\"ATP synthesis coupled proton transport\")",
      "concept": {
        "name": "ATP synthesis coupled proton transport",
        "namespace": "GO"
      },
      "function": "BiologicalProcess",
      "id": "7034d444cfa797b02fecba5764526913"
    },
    {
      "bel": "bp(GO:\"anterograde axonal protein transport\")",
      "concept": {
        "name": "anterograde axonal protein transport",
        "namespace": "GO"
      },
      "function": "BiologicalProcess",
      "id": "35ebd956d85fb57273a53f4faf10d196"
    },
    {
      "bel": "bp(GO:\"axonal transport\")",
      "concept": {
        "name": "axonal transport",
        "namespace": "GO"
      },
      "function": "BiologicalProcess",
      "id": "c9d614fb05004498d4069f216f0458c8"
    },
    {
      "bel": "bp(GO:\"cell death\")",
      "concept": {
        "name": "cell death",
        "namespace": "GO"
      },
      "function": "BiologicalProcess",
      "id": "07a2f2734c3682bcb47105485c15b346"
    },
    {
      "bel": "bp(GO:\"generation of neurons\")",
      "concept": {
        "name": "generation of neurons",
        "namespace": "GO"
      },
      "function": "BiologicalProcess",
      "id": "0df1f54487a90beeac83692bb406f5a0"
    },
    {
      "bel": "bp(GO:\"intracellular signal transduction\")",
      "concept": {
        "name": "intracellular signal transduction",
        "namespace": "GO"
      },
      "function": "BiologicalProcess",
      "id": "5976d5b391ca9a4a54bf30966e6ad68f"
    },
    {
      "bel": "bp(GO:\"maintenance of synapse structure\")",
      "concept": {
        "name": "maintenance of synapse structure",
        "namespace": "GO"
      },
      "function": "BiologicalProcess",
      "id": "a09a837526cf78a03f4f0d8f364f9ff7"
    },
    {
      "bel": "bp(GO:\"mitochondrion organization\")",
      "concept": {
        "name": "mitochondrion organization",
        "namespace": "GO"
      },
      "function": "BiologicalProcess",
      "id": "8d88a8bdfbb3b7cab315ed7796ad9990"
    },
    {
      "bel": "bp(GO:\"neurofibrillary tangle assembly\")",
      "concept": {
        "name": "neurofibrillary tangle assembly",
        "namespace": "GO"
      },
      "function": "BiologicalProcess",
      "id": "1f82590453fa284e3e950f8c5eb3e2da"
    },
    {
      "bel": "bp(GO:\"neuron death\")",
      "concept": {
        "name": "neuron death",
        "namespace": "GO"
      },
      "function": "BiologicalProcess",
      "id": "5af039c1f3120f7215931236c3c03804"
    },
    {
      "bel": "bp(GO:\"synaptic signaling\")",
      "concept": {
        "name": "synaptic signaling",
        "namespace": "GO"
      },
      "function": "BiologicalProcess",
      "id": "47e244f71f5d21a426ba920c40e7b9ed"
    },
    {
      "bel": "bp(GO:behavior)",
      "concept": {
        "name": "behavior",
        "namespace": "GO"
      },
      "function": "BiologicalProcess",
      "id": "77f1822074b59deb82cc4661eb6d5aa5"
    },
    {
      "bel": "bp(GO:cognition)",
      "concept": {
        "name": "cognition",
        "namespace": "GO"
      },
      "function": "BiologicalProcess",
      "id": "24220ec2073c35bcd945681ee9c6ea38"
    },
    {
      "bel": "bp(GO:endocytosis)",
      "concept": {
        "name": "endocytosis",
        "namespace": "GO"
      },
      "function": "BiologicalProcess",
      "id": "4dfe1bc8ad46020348f422e95ecbfb54"
    },
    {
      "bel": "bp(GO:macropinocytosis)",
      "concept": {
        "name": "macropinocytosis",
        "namespace": "GO"
      },
      "function": "BiologicalProcess",
      "id": "f8b4dc0df6ea2dc25bcba995781d363f"
    },
    {
      "bel": "bp(GO:memory)",
      "concept": {
        "name": "memory",
        "namespace": "GO"
      },
      "function": "BiologicalProcess",
      "id": "e03a718b44a1ff30acea5c31966879a9"
    },
    {
      "bel": "bp(HP:Neurodegeneration)",
      "concept": {
        "name": "Neurodegeneration",
        "namespace": "HP"
      },
      "function": "BiologicalProcess",
      "id": "d24e0a48dfe9951234e42f57ab8a2c78"
    },
    {
      "bel": "bp(MESH:\"Cell Survival\")",
      "concept": {
        "name": "Cell Survival",
        "namespace": "MESH"
      },
      "function": "BiologicalProcess",
      "id": "c6f26bea83787c63169a3fcb728da799"
    },
    {
      "bel": "bp(MESH:\"Neuronal Plasticity\")",
      "concept": {
        "name": "Neuronal Plasticity",
        "namespace": "MESH"
      },
      "function": "BiologicalProcess",
      "id": "7e5d48cf7a27a09a15d969d961c71347"
    },
    {
      "bel": "bp(MESH:Aging)",
      "concept": {
        "name": "Aging",
        "namespace": "MESH"
      },
      "function": "BiologicalProcess",
      "id": "a7dfc4174eeddedd615321940d8c5728"
    },
    {
      "bel": "complex(a(CONSO:\"Tau aggregates\"), a(GO:\"cell surface\"))",
      "function": "Complex",
      "id": "1664ff0ed250bb87d1a1196e72be8521",
      "members": [
        {
          "bel": "a(CONSO:\"Tau aggregates\")",
          "concept": {
            "name": "Tau aggregates",
            "namespace": "CONSO"
          },
          "function": "Abundance",
          "id": "8e1da50e6008ffdd1b37825776666311"
        },
        {
          "bel": "a(GO:\"cell surface\")",
          "concept": {
            "name": "cell surface",
            "namespace": "GO"
          },
          "function": "Abundance",
          "id": "e5fa02451051e3ddcc8a6c3289445bc9"
        }
      ]
    },
    {
      "bel": "complex(a(CONSO:\"Tau aggregates\"), a(MESH:\"Heparan Sulfate Proteoglycans\"))",
      "function": "Complex",
      "id": "94e191c401c606e12e69219af4d6e90d",
      "members": [
        {
          "bel": "a(CONSO:\"Tau aggregates\")",
          "concept": {
            "name": "Tau aggregates",
            "namespace": "CONSO"
          },
          "function": "Abundance",
          "id": "8e1da50e6008ffdd1b37825776666311"
        },
        {
          "bel": "a(MESH:\"Heparan Sulfate Proteoglycans\")",
          "concept": {
            "name": "Heparan Sulfate Proteoglycans",
            "namespace": "MESH"
          },
          "function": "Abundance",
          "id": "ca0c2459dc50ea6388244eec62e9d530"
        }
      ]
    },
    {
      "bel": "complex(a(GO:vesicle), a(MESH:\"Cell Membrane\"))",
      "function": "Complex",
      "id": "d43244f1e20ba4c5575a24258255e754",
      "members": [
        {
          "bel": "a(GO:vesicle)",
          "concept": {
            "name": "vesicle",
            "namespace": "GO"
          },
          "function": "Abundance",
          "id": "289ddc95e92756879e07751d19bf7025"
        },
        {
          "bel": "a(MESH:\"Cell Membrane\")",
          "concept": {
            "name": "Cell Membrane",
            "namespace": "MESH"
          },
          "function": "Abundance",
          "id": "5f1f124138addc7af92d1beca50bdbd4"
        }
      ]
    },
    {
      "bel": "complex(a(MESH:\"Receptors, N-Methyl-D-Aspartate\"), p(HGNC:MAPT))",
      "function": "Complex",
      "id": "ba5303d59a2cdc3683b82f22d082b07b",
      "members": [
        {
          "bel": "a(MESH:\"Receptors, N-Methyl-D-Aspartate\")",
          "concept": {
            "name": "Receptors, N-Methyl-D-Aspartate",
            "namespace": "MESH"
          },
          "function": "Abundance",
          "id": "9243c01ac01a47ab2b889a759940325e"
        },
        {
          "bel": "p(HGNC:MAPT)",
          "concept": {
            "name": "MAPT",
            "namespace": "HGNC"
          },
          "function": "Protein",
          "id": "7d1009217050e75d549c8c5aa83309a8"
        }
      ]
    },
    {
      "bel": "complex(p(HGNC:APAF1), p(HGNC:CYCS))",
      "function": "Complex",
      "id": "4a8cf3655e4314393babc00376adc237",
      "members": [
        {
          "bel": "p(HGNC:APAF1)",
          "concept": {
            "name": "APAF1",
            "namespace": "HGNC"
          },
          "function": "Protein",
          "id": "fe4e68a558e4b0d2a0a8955e1b6a29c8"
        },
        {
          "bel": "p(HGNC:CYCS)",
          "concept": {
            "name": "CYCS",
            "namespace": "HGNC"
          },
          "function": "Protein",
          "id": "0df17b63811ab39cf4d3f02004125f2c"
        }
      ]
    },
    {
      "bel": "complex(p(HGNC:CHRM1), p(HGNC:MAPT))",
      "function": "Complex",
      "id": "b57c22111158028bf76c43977a17aec2",
      "members": [
        {
          "bel": "p(HGNC:CHRM1)",
          "concept": {
            "name": "CHRM1",
            "namespace": "HGNC"
          },
          "function": "Protein",
          "id": "ceab2e156e166244b1e2a4969a5c25ab"
        },
        {
          "bel": "p(HGNC:MAPT)",
          "concept": {
            "name": "MAPT",
            "namespace": "HGNC"
          },
          "function": "Protein",
          "id": "7d1009217050e75d549c8c5aa83309a8"
        }
      ]
    },
    {
      "bel": "complex(p(HGNC:CHRM3), p(HGNC:MAPT))",
      "function": "Complex",
      "id": "a70987fae4784f01f351fe4452871070",
      "members": [
        {
          "bel": "p(HGNC:CHRM3)",
          "concept": {
            "name": "CHRM3",
            "namespace": "HGNC"
          },
          "function": "Protein",
          "id": "4b64c0337579caf934ce7d032d66b1f2"
        },
        {
          "bel": "p(HGNC:MAPT)",
          "concept": {
            "name": "MAPT",
            "namespace": "HGNC"
          },
          "function": "Protein",
          "id": "7d1009217050e75d549c8c5aa83309a8"
        }
      ]
    },
    {
      "bel": "complex(p(HGNC:DNM1L), p(HGNC:MAPT))",
      "function": "Complex",
      "id": "14f12f3faf1f513f89bd38c0ba3a0ee8",
      "members": [
        {
          "bel": "p(HGNC:DNM1L)",
          "concept": {
            "name": "DNM1L",
            "namespace": "HGNC"
          },
          "function": "Protein",
          "id": "000fa66835a50916da27dc7814d74ae7"
        },
        {
          "bel": "p(HGNC:MAPT)",
          "concept": {
            "name": "MAPT",
            "namespace": "HGNC"
          },
          "function": "Protein",
          "id": "7d1009217050e75d549c8c5aa83309a8"
        }
      ]
    },
    {
      "bel": "p(HGNC:APAF1)",
      "concept": {
        "name": "APAF1",
        "namespace": "HGNC"
      },
      "function": "Protein",
      "id": "fe4e68a558e4b0d2a0a8955e1b6a29c8"
    },
    {
      "bel": "p(HGNC:CASP9)",
      "concept": {
        "name": "CASP9",
        "namespace": "HGNC"
      },
      "function": "Protein",
      "id": "60a8c30c5151b007173c998ccc0468eb"
    },
    {
      "bel": "p(HGNC:CHRM1)",
      "concept": {
        "name": "CHRM1",
        "namespace": "HGNC"
      },
      "function": "Protein",
      "id": "ceab2e156e166244b1e2a4969a5c25ab"
    },
    {
      "bel": "p(HGNC:CHRM3)",
      "concept": {
        "name": "CHRM3",
        "namespace": "HGNC"
      },
      "function": "Protein",
      "id": "4b64c0337579caf934ce7d032d66b1f2"
    },
    {
      "bel": "p(HGNC:CYCS)",
      "concept": {
        "name": "CYCS",
        "namespace": "HGNC"
      },
      "function": "Protein",
      "id": "0df17b63811ab39cf4d3f02004125f2c"
    },
    {
      "bel": "p(HGNC:DNM1L)",
      "concept": {
        "name": "DNM1L",
        "namespace": "HGNC"
      },
      "function": "Protein",
      "id": "000fa66835a50916da27dc7814d74ae7"
    },
    {
      "bel": "p(HGNC:MAPT)",
      "concept": {
        "name": "MAPT",
        "namespace": "HGNC"
      },
      "function": "Protein",
      "id": "7d1009217050e75d549c8c5aa83309a8"
    },
    {
      "bel": "p(HGNC:MAPT, frag(\"1_421\"))",
      "concept": {
        "name": "MAPT",
        "namespace": "HGNC"
      },
      "function": "Protein",
      "id": "0cbc2f7487e2ad378f21d94ff24c96b9",
      "variants": [
        {
          "kind": "frag",
          "start": 1,
          "stop": 421
        }
      ]
    },
    {
      "bel": "p(HGNC:MAPT, frag(\"421_?\"))",
      "concept": {
        "name": "MAPT",
        "namespace": "HGNC"
      },
      "function": "Protein",
      "id": "ae8c6e35f6e56ef6a822fbfedc7f8ad7",
      "variants": [
        {
          "kind": "frag",
          "start": 421,
          "stop": "?"
        }
      ]
    },
    {
      "bel": "p(HGNC:MAPT, pmod(Ph))",
      "concept": {
        "name": "MAPT",
        "namespace": "HGNC"
      },
      "function": "Protein",
      "id": "a8fb3a87d5a0672c07462bb17c8b0947",
      "variants": [
        {
          "concept": {
            "name": "Ph",
            "namespace": "bel"
          },
          "kind": "pmod"
        }
      ]
    },
    {
      "bel": "p(HGNC:MAPT, pmod(Ph, Ser, 396))",
      "concept": {
        "name": "MAPT",
        "namespace": "HGNC"
      },
      "function": "Protein",
      "id": "d20659abb6d812839958a31e9d5d259b",
      "variants": [
        {
          "code": "Ser",
          "concept": {
            "name": "Ph",
            "namespace": "bel"
          },
          "kind": "pmod",
          "pos": 396
        }
      ]
    },
    {
      "bel": "p(HGNC:MAPT, pmod(Ph, Thr, 181))",
      "concept": {
        "name": "MAPT",
        "namespace": "HGNC"
      },
      "function": "Protein",
      "id": "0b33aa1bee79f21990b8e145bc2b2088",
      "variants": [
        {
          "code": "Thr",
          "concept": {
            "name": "Ph",
            "namespace": "bel"
          },
          "kind": "pmod",
          "pos": 181
        }
      ]
    },
    {
      "bel": "p(HGNC:PRNP)",
      "concept": {
        "name": "PRNP",
        "namespace": "HGNC"
      },
      "function": "Protein",
      "id": "0df8caec1eedc2d8cf6b578ada69c73f"
    },
    {
      "bel": "path(MESH:\"Alzheimer Disease\")",
      "concept": {
        "name": "Alzheimer Disease",
        "namespace": "MESH"
      },
      "function": "Pathology",
      "id": "2ae8307f5fd59056199369691367cc96"
    },
    {
      "bel": "path(MESH:\"Brain Injuries, Traumatic\")",
      "concept": {
        "name": "Brain Injuries, Traumatic",
        "namespace": "MESH"
      },
      "function": "Pathology",
      "id": "3c4b2cad0bdee5fabf9b605909a70f3b"
    },
    {
      "bel": "path(MESH:\"Cerebral Amyloid Angiopathy, Familial\")",
      "concept": {
        "name": "Cerebral Amyloid Angiopathy, Familial",
        "namespace": "MESH"
      },
      "function": "Pathology",
      "id": "7890e9713f833717b7e40c78217d1558"
    },
    {
      "bel": "path(MESH:\"Frontotemporal Dementia\")",
      "concept": {
        "name": "Frontotemporal Dementia",
        "namespace": "MESH"
      },
      "function": "Pathology",
      "id": "876d8dfbadfb211122e2ba889d763c19"
    },
    {
      "bel": "path(MESH:\"Plaque, Amyloid\")",
      "concept": {
        "name": "Plaque, Amyloid",
        "namespace": "MESH"
      },
      "function": "Pathology",
      "id": "ff45c3caeb411cd232d96d6ed01854d5"
    },
    {
      "bel": "path(MESH:\"Supranuclear Palsy, Progressive\")",
      "concept": {
        "name": "Supranuclear Palsy, Progressive",
        "namespace": "MESH"
      },
      "function": "Pathology",
      "id": "e020e57c09a4c1910b18ec35c70e598f"
    },
    {
      "bel": "path(MESH:Disease)",
      "concept": {
        "name": "Disease",
        "namespace": "MESH"
      },
      "function": "Pathology",
      "id": "0c4021b2257b83799cf001fb0c2cf1ab"
    },
    {
      "bel": "path(MESH:Tauopathies)",
      "concept": {
        "name": "Tauopathies",
        "namespace": "MESH"
      },
      "function": "Pathology",
      "id": "e7af59eca49dd3e30ab0fb75db41527a"
    }
  ]
}